date,open,high,low,close,volume,title,description,title_sentiment,desc_sentiment,daily_change_pct,market_sentiment,next_day_change_pct,next_day_sentiment
2018-03-05 13:00:54.184,106.6,109.0,106.31,106.99,785140.0,Laurus Labs gains 3% on zero observations from USFDA,The company received its maiden approval from USFDA for Tenofovir Disoproxil Fumarate tablets 300mg.,positive,positive,0.3658536585365859,neutral,-0.1996007984031877,neutral
2018-05-10 23:01:53.867,97.2,98.38,95.6,97.8,256340.0,Laurus Labs Q4 net down 36% at ₹ 45 cr,"Laurus Labs Ltd today said its consolidated net profit for the quarter ended March 31, 2018 was down by over 36 per cent to ₹ 45 crore as against ₹71 crore during the first quarter of the last fiscal.",negative,negative,0.6172839506172781,neutral,-1.4784394250513468,negative
2018-05-13 23:00:22.215,97.4,97.4,94.63,95.96,112965.0,Laurus Labs Q4 net dips 36%,"Laurus Labs Ltd’s net profit decreased 36.8 per cent at ₹45 crore in the fourth quarter ended March 31, 2018, compared with ₹71.3 crore in the corresponding quarter of the previous financial year. The",neutral,negative,-1.4784394250513468,negative,-2.050113895216405,negative
2018-05-15 18:00:34.233,95.6,95.6,92.09,92.4,148840.0,"Tata Motors, ACC, PFC, REC hit 52-week low","Reliance Capital, Reliance Naval, Unitech, Vakrangee, Laurus Labs, Glenmark Pharma, Capital First and Allahabad Bank were among 29 stocks from the BSE500 index hit their respective 52-week lows.",neutral,neutral,-3.347280334728022,negative,-0.5405405405405406,neutral
2018-06-08 23:02:07.558,93.8,97.98,93.04,96.8,212925.0,Laurus Labs promoter raises stake through open market purchase,"Dr Satyanarayana Chava, Promoter & Director, Laurus Labs, has increased his stake in the company through open market purchase. He has acquired 1,70,600 shares of the company between June 4 and Jun",positive,positive,3.1982942430703627,positive,3.295114141101124,positive
2018-07-18 18:02:22.035,91.3,91.6,88.04,89.4,84740.0,Laurus Labs Q1 PAT may dip 19.6% YoY to Rs. 31.3 cr: Kotak,"Net Sales are expected to increase by 2.5 percent Y-o-Y (down 10.1 percent Q-o-Q) to Rs. 503.6 crore, according to Kotak.",neutral,positive,-2.0810514786418306,negative,-0.6696428571428509,neutral
2018-08-06 13:00:38.853,87.62,88.53,86.66,87.0,1346940.0,Laurus Labs hits record low on disappointing Q1 results,The stock slipped 8% to Rs 430 on the BSE in intra-day trade after the company reported 57% year-on-year decline in net profit at Rs 166 million in June quarter.,negative,negative,-0.7076010043369145,neutral,1.1956771671648565,positive
2018-08-07 23:01:00.740,86.98,88.4,86.41,88.02,158000.0,Laurus Labs to invest ₹200 cr on capacity expansion,Laurus Labs Ltd will invest ₹200-300 crore in capacity expansion over the next 12 months. “The production capacity of active pharmaceutical ingredients (APIs) will be augmented by expansion of existin,neutral,positive,1.1956771671648565,positive,0.467342984155929,neutral
2018-08-30 10:00:48.284,91.9,93.79,87.54,87.9,1590820.0,Laurus Labs rises nearly 6% post USFDA approval for diabetes drug,"The company has received an approval from USFDA (United States Food and Drug Administration) for Metformin Hydrochloride Tablets USP 500mg, 850mg and 1000mg which are used for treatment of diabetes.",positive,positive,-4.352557127312295,negative,-0.7807196198234869,neutral
2018-08-30 13:01:08.088,88.38,88.62,87.02,87.69,811830.0,Laurus Labs climbs 6% on USFDA approval,The stock rose 5.84 per cent to hit a high of Rs 464.35 on the BSE.,positive,positive,-0.7807196198234869,neutral,-0.648464163822534,neutral
2018-10-17 13:03:02.366,81.82,82.64,80.0,80.48,1120440.0,Laurus Labs Q2 PAT may dip 49.4% YoY to Rs. 24.5 cr: Sharekhan,"Net Sales are expected to increase by 9.9 percent Y-o-Y (up 9.9 percent Q-o-Q) to Rs. 592.5 crore, according to Sharekhan.",neutral,positive,-1.6377413835247976,negative,-4.634691848906566,negative
2018-10-17 23:03:01.037,81.82,82.64,80.0,80.48,1120440.0,Laurus Labs Q2 PAT may dip 46.7% YoY to Rs. 30 cr: HDFC Securities,"Net Sales are expected to increase by 2.8 percent Y-o-Y (up 2.7 percent Q-o-Q) to Rs. 550 crore, according to HDFC Securities.",neutral,positive,-1.6377413835247976,negative,-4.634691848906566,negative
2018-10-23 23:00:43.895,75.77,78.08,70.77,71.6,1267230.0,Laurus Labs transfers new drug application to CASI Pharma,"Laurus Labs has transferred its USFDA-approved Abbreviated New Drug Application (ANDA) of Tenofovir Disoproxil Fumarate (TDF) to CASI Pharmaceuticals, Inc. As part of the transaction, the company, in",neutral,neutral,-5.5034974264220695,negative,-4.42726633872102,negative
2018-10-24 10:01:43.334,75.77,78.08,70.77,71.6,1267230.0,Laurus Labs transfers ownership rights of hepatitis B drug to CASI Pharma,"CASI will be using the drug in China, for which it will make certain up-front and milestone payments",neutral,neutral,-5.5034974264220695,negative,-4.42726633872102,negative
2018-11-02 23:02:18.249,71.2,73.8,70.8,73.0,614865.0,Laurus Labs gets one observation for API plant in Visakhapatnam,The company called the observation “procedural”.,neutral,neutral,2.528089887640445,positive,-1.8463611859838331,negative
2018-12-03 10:00:52.085,77.34,80.0,77.3,78.18,225865.0,"In Focus: Sun Pharma,  Jet Airways, Prabhat Dairy, Laurus Labs and Maruti Suzuki",Here are a few stocks which may buzz the most in todays session.,neutral,neutral,1.0861132660977546,positive,-2.7795405508313387,negative
2019-01-31 23:00:18.624,72.2,73.25,70.2,70.7,708885.0,Laurus Labs Q3 net profit down by 49% to Rs 17.8 cr,"According to a press release issued by the drug maker, revenues from operations stood at Rs 529.5 crore up 10.6 percent.",negative,positive,-2.0775623268698062,negative,-3.9726027397260353,negative
2019-01-31 23:02:16.054,72.2,73.25,70.2,70.7,708885.0,"Laurus Labs Standalone December 2018 Net Sales at Rs 512.78 crore, up 8.23% Y-o-Y","Laurus Labs Standalone December 2018 Net Sales at Rs 512.78 crore, up 8.23% Y-o-Y",positive,positive,-2.0775623268698062,negative,-3.9726027397260353,negative
2019-02-03 18:00:59.432,73.0,74.51,70.1,70.1,149445.0,Laurus Labs gets USFDA nod for HIV drug,"Laurus Labs said Sunday it has received tentative approval from the United States Food and Drug Administration for TLD, which is one of preferred first line regimen for the treatment of HIV. The appro",neutral,positive,-3.9726027397260353,negative,-2.479799387015884,negative
2019-02-04 10:02:10.850,73.0,74.51,70.1,70.1,149445.0,"Stocks in the news: Vedanta, Laurus Labs, Xelpmoc Design, Zee Entertainment, DHFL and NIIT Tech",Here are a few stocks which may buzz the most in today's trade.,neutral,neutral,-3.9726027397260353,negative,-2.479799387015884,negative
2019-03-11 18:01:16.265,74.44,74.44,71.66,72.62,1065900.0,Laurus Labs gets USFDA nod for Malaria treatment tablets,Laurus Labs Ltd has received a final approval from United States Food and Drug Administration (US FDA) for Hydroxychloroquine Tablets.The approved drug is used for treatment of certain type of Malaria,neutral,positive,-2.444922084900582,negative,-1.2465753424657489,negative
2019-03-12 10:00:46.879,74.44,74.44,71.66,72.62,1065900.0,"USFDA okays Laurus’ HIV, malaria drugs","Laurus Labs said it had received the final approval from the US Food and Drug Administration (USFDA) for Hydroxychloroquine tablets 200 mg, a product used in the treatment of certain types of malaria.",neutral,positive,-2.444922084900582,negative,-1.2465753424657489,negative
2019-03-12 13:00:59.657,73.0,76.8,71.4,72.09,1943580.0,Laurus Labs jumps 2% on USFDA approval for malaria drug,The US Food and Drug Administration (FDA) has given its approval for Laurus Labs' Hydroxychloroquine tablets in the strength of 200 mg.,positive,positive,-1.2465753424657489,negative,3.838771593090208,positive
2019-03-26 18:01:56.354,79.18,81.1,78.0,80.2,2245875.0,Larus Labs enters agreement with Global Fund for supply of AIDS drugs,Through this agreement Laurus Labs will have the volume commitments from the Global Fund for the treatment of HIV/AIDS,positive,neutral,1.2882040919424047,positive,0.860349127182042,neutral
2019-03-26 18:02:49.435,79.18,81.1,78.0,80.2,2245875.0,Laurus Labs seals deal with Global Fund to supply ARV combination medicine,"Laurus staved off competition from drug makers such as Mylan, Cipla, Sun Pharma and Macleods to win the contract.",positive,positive,1.2882040919424047,positive,0.860349127182042,neutral
2019-05-02 23:00:09.251,79.99,81.19,77.8,79.44,522375.0,"Laurus Labs Standalone March 2019 Net Sales at Rs 617.64 crore, up 13.01% Y-o-Y","Laurus Labs Standalone March 2019 Net Sales at Rs 617.64 crore, up 13.01% Y-o-Y",positive,positive,-0.6875859482435269,neutral,-2.4185463659147777,negative
2019-05-02 23:01:59.982,79.99,81.19,77.8,79.44,522375.0,Laurus Labs net profit down 4 % at Rs 43.2 Cr in Q4,"According to a release issued by the city-based drug maker, revenues was up by nearly 13 per cent to Rs 637 crore compared to Rs 565 crore during the same quarter in FY18.

",negative,positive,-0.6875859482435269,neutral,-2.4185463659147777,negative
2019-06-14 23:00:26.682,67.2,68.4,66.75,68.4,153685.0,Laurus Labs gets two observations from USFDA for its Visakhapatnam facilities,No data integrity issues were observed in the inspection,neutral,negative,1.7857142857142898,positive,-1.7004858531008824,negative
2019-06-17 10:02:41.903,69.98,69.98,68.0,68.79,253030.0,Laurus Labs receives 2 observations for API units at Visakhapatnam,"This is a regular surveillance audit by USFDA, and no data integrity issues were observed in the inspection.",neutral,neutral,-1.7004858531008824,negative,-0.2941176470588277,neutral
2019-07-05 10:00:18.092,70.44,70.81,68.2,68.4,77080.0,"Board Meetings Today: Colgate, Sundaram Finance, Mayur Uniquoters and Laurus Labs",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges. ,neutral,neutral,-2.896081771720602,negative,-1.0174418604651203,negative
2019-07-11 10:01:21.066,68.3,69.6,68.29,68.84,61605.0,"Board Meetings Today: Den Network, Vedanta, Laurus Labs and Punjab & Sindh Bank",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges. ,neutral,neutral,0.7906295754026447,neutral,2.148521989906286,positive
2019-07-12 18:00:20.745,69.35,73.78,68.08,70.84,242885.0,"Laurus Labs reports successful completion of USFDA inspection at Unit 4, Visakhapatnam; stock rises 3%","The Company has announced that it has completed the US Food and Drug Administration inspection of Unit 4 at Visakhapatnam, Andhra Pradesh, without any observations and no form 483 issued.",positive,neutral,2.148521989906286,positive,-3.95085857880776,negative
2019-07-22 18:00:32.059,70.2,70.37,67.81,68.2,78065.0,Laurus Labs’ partner Rising Pharma launches neuropathic pain capsules in US,"Drug firm Laurus Labs on Monday said its exclusive distribution partner, Rising Pharmaceuticals, has launched generic Pregabalin capsules indicated for the management of neuropathic pain in the Americ",neutral,positive,-2.849002849002849,negative,1.4210919970082316,positive
2019-07-22 23:00:31.679,70.2,70.37,67.81,68.2,78065.0,Laurus Labs launches generic of Lyrica,"Laurus Labs Ltd has launched the generic version of Lyrica, (pregabalin) capsules in all commercially available strengths in the US market along with its exclusive distribution partner Rising Pharmace",neutral,positive,-2.849002849002849,negative,1.4210919970082316,positive
2019-08-02 23:00:08.959,66.86,68.0,66.02,68.0,79045.0,Laurus Labs Q1 PAT down 9% at Rs 15 cr,"Laurus Labs’ profit after tax for the quarter ended June 30 was down by nine per cent to Rs 15.1 crore against Rs 16.6 crore for the first quarter of the last fiscal, the drug maker said here on Frida",negative,negative,1.7050553395154062,positive,0.5825854196189648,neutral
2019-09-05 13:01:45.678,66.46,68.82,66.46,68.0,68685.0,Laurus Labs gains 3% on EIR from USFDA for Vizag units,"Laurus Labs is among the three companies to receive an approval for TLE 400, an antiretroviral therapy product",positive,positive,2.3171832681312163,positive,2.058567700782838,positive
2019-09-06 18:00:13.118,66.46,68.82,66.46,68.0,68685.0,Laurus Labs units get USFDA EIR,Laurus Labs said it has received Establishment Inspection Report (EIR) from U.S. Food and Drug Administration for its active pharmaceutical ingredient (API) Units 1 and 3 in Visakhapatnam. The units w,neutral,neutral,2.3171832681312163,positive,2.058567700782838,positive
2019-09-19 10:00:26.744,70.53,70.53,67.0,68.21,442765.0,"Laurus Labs to acquire Phekolong Pharmaceuticals, South Africa","This transaction will provide Laurus access to the South African public antiretroviral (ARV) sector, which manages the world's largest public ARV programme.",neutral,positive,-3.2893804055012152,negative,2.63929618768328,positive
2019-09-19 13:01:14.606,68.2,70.2,68.2,70.0,118910.0,Laurus Labs to acquire South Africa’s Aspen Pharmacare subsidiary,"Laurus Labs , a research and development driven pharmaceutical company, has agreed to acquire 100% shares of Phekolong Pharmaceuticals Pty Ltd, a wholly owned subsidiary company of Pharmacare Ltd. t/a",neutral,positive,2.63929618768328,positive,-1.2926136363636516,negative
2019-11-01 13:04:55.999,81.4,83.76,75.1,75.6,6737465.0,"Laurus Labs Standalone September 2019 Net Sales at Rs 705.86 crore, up 22.84% Y-o-Y","Laurus Labs Standalone September 2019 Net Sales at Rs 705.86 crore, up 22.84% Y-o-Y",positive,positive,-7.125307125307138,negative,-2.493438320209981,negative
2019-11-04 13:02:18.498,75.0,76.3,73.73,73.9,539625.0,Laurus Labs Q2: Change in product mix and improved margins key positives,Laurus Labs Q2: Change in product mix and improved margins key positives,positive,positive,-1.466666666666659,negative,0.1216380591971934,neutral
2019-11-08 18:00:48.549,74.2,74.74,72.82,73.28,441180.0,Laurus Labs gets two observations from USFDA for its Unit 2,"Laurus Labs Ltd has completed the US Food and Drug Administration (USFDA) inspection of its Unit – 2 (FDF&amp;amp;API integrated facility), located at APSEZ, Atchutapuram, Visakhapatnam, Andhra Prades",neutral,neutral,-1.239892183288412,negative,1.8036623984579403,positive
2019-11-11 10:02:19.813,72.63,74.62,72.63,73.94,322975.0,"Top stocks in focus: Lupin, IDBI Bank, Laurus Labs, Goa Carbon",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.8036623984579403,positive,-2.770270270270266,negative
2019-11-11 13:00:44.809,72.63,74.62,72.63,73.94,322975.0,Laurus Labs shares up on USFDA observations on Visakhapatnam unit,Laurus Labs shares went up today on the bourses after the company release said that it has received two observations from U.S. Food and Drug Administration for its FDF &amp;amp; API Integrated Facilit,neutral,positive,1.8036623984579403,positive,-2.770270270270266,negative
2019-11-21 18:02:46.165,65.61,68.8,65.6,66.9,426005.0,Laurus Labs gets 3 USFDA observations in API product inspection,"Laurus Labs Ltd has completed pre-approval inspection for an Active Pharmaceutical Ingredient (API) product manufactured at its Units 1 and 3, located at JN Pharma City, Parawada, Visakhapatnam, Andhr",neutral,positive,1.966163694558766,positive,-0.9911242603550112,negative
2019-11-21 23:01:53.026,65.61,68.8,65.6,66.9,426005.0,Laurus Labs gets 3 observations from USFDA for Visakhapatnam facility,"The company has completed the pre approval inspection (PAI) for an active pharmaceutical ingredient (API) manufactured at its Units 1&3, located at Visakhapatnam by the United States Food and Drug Administration, Laurus Labs said in a filing to the BSE. The inspection was completed with three observations, 'which are procedural in nature'.",neutral,positive,1.966163694558766,positive,-0.9911242603550112,negative
2019-11-22 10:01:35.333,65.61,68.8,65.6,66.9,426005.0,"Top stocks in focus: RITES, BHEL, Laurus Labs, Tata Power",Check out the companies which will be in focus during trade today based on recent and latest news developments.,neutral,neutral,1.966163694558766,positive,-0.9911242603550112,negative
2019-12-20 10:03:24.736,74.78,77.31,73.23,75.95,1288360.0,Laurus Labs (₹370.3): Buy,"Investors with a short-term horizon can buy the stock of Laurus Labs at current levels. The stock jumped 4.2 per cent accompanied by above average volume on Thursday, breaking above a key immediate re",neutral,positive,1.56458946242311,positive,-4.000000000000008,negative
2020-01-27 13:04:57.868,84.4,86.79,84.4,85.31,637645.0,"Pharma shares gain; Dr Reddy's, Alembic, Divis, Laurus Labs hit 52-wk highs","Wockhardt, Strides Pharma Science, Alembic Pharmaceuticals, Pfizer and IOL Chemicals & Pharmaceuticals were up in the range of 5 per cent to 9 per cent in intra-day trade today.",positive,positive,1.0781990521326974,positive,2.0930232558139505,positive
2020-01-30 23:01:54.807,91.98,91.99,83.0,86.1,7776435.0,Laurus Labs net trebles at ₹73.5 cr,"Laurus Labs Ltd’s net profit more than tripled at ₹73.5 crore in the third quarter ended December 31, 2019 as against ₹17.8 crore in the corresponding quarter of previous financial year. The total rev",neutral,positive,-6.392694063926951,negative,-0.6106153123532129,neutral
2020-03-03 10:01:41.616,85.18,85.84,82.4,83.39,437845.0,Ideas for Profit | Laurus Labs Q3: Improving product mix a key catalyst,Ideas for Profit | Laurus Labs Q3: Improving product mix a key catalyst,neutral,neutral,-2.101432261094161,negative,-1.0072616537830867,negative
2020-03-26 18:02:16.074,68.42,70.55,64.8,65.4,538785.0,Laurus Labs prepones the date for paying dividend to its shareholders,"The Dividend amount will be paid to the shareholders of the Company whose names appear in the register of members as on March 25, 2020 the Record Date only as originally fixed for the purpose and there is no change in the Record Date.",neutral,neutral,-4.413914060216305,negative,-4.676895839480675,negative
2020-03-27 10:02:45.814,68.42,70.55,64.8,65.4,538785.0,"Stocks to watch today on March 27: Laurus Labs, Wabco India, Sonata Software, Sanghvi Movers, Lupin, Mindtree, Motilal Oswal among others are the top stocks to watch out for in Friday's trading session","Stocks to watch today on March 27: Laurus Labs, Wabco India, Sonata Software, Sanghvi Movers, Lupin, Mindtree, Motilal Oswal among others are the top stocks to watch out for in Friday's trading session",neutral,neutral,-4.413914060216305,negative,-4.676895839480675,negative
2020-03-27 13:00:22.072,68.42,70.55,64.8,65.4,538785.0,"COVID19: Laurus Labs donates 2 lakh Hydroxychloroquine tablets, Rs 1 crore",Laurus Labs Ltd has donated two lakh tablets of Hydroxychloroquine (HCQ) Tablets as mitigation initiative in the wake of Coronavirus (Covid-19) and also ₹50 lakh each for supporting suppression measur,neutral,neutral,-4.413914060216305,negative,-4.676895839480675,negative
2020-03-27 23:00:41.432,68.42,70.55,64.8,65.4,538785.0,Coronavirus: Laurus Labs to supply Hydroxychloroquine for clinical trials in the US,The company has received an approval from the US Food & Drug Administration (USFDA) to market Hydroxychloroquine Sulphate tablets,neutral,positive,-4.413914060216305,negative,-4.676895839480675,negative
2020-04-07 13:03:58.484,81.2,84.89,77.2,78.2,1597760.0,"D-Street Buzz: Pharma stocks shine; Cadila, Laurus Labs, Biocon shares jump up to 15%","Brokerages do not see a meaningful adverse impact of the lockdown, which is in its second week, on the earnings of pharma players.",positive,negative,-3.694581280788177,negative,0.1219512195121881,neutral
2020-04-20 06:00:00.000,81.23,82.76,81.23,81.4,1197410.0,"Top stocks in focus: Infosys, Tata Motors, HDFC Bank, Nalco, Apollo Tyres, Cadila, Laurus Labs",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.2092822848701239,neutral,11.72029702970297,positive
2020-04-22 09:57:00.000,93.68,98.8,92.07,93.98,7073705.0,Laurus Labs surges 50% in one month on growth prospects in US market,"The stock hit a 52-week high of Rs 494, up 9 per cent on the BSE on Wednesday, surging 20 per cent in past two trading days on expectation of strong growth prospects in United States.",positive,positive,0.3202391118701933,neutral,-2.0920502092050213,negative
2020-04-22 12:19:00.000,95.6,95.95,93.0,93.6,1808120.0,Share market update: 10 stocks hit 52-week highs on NSE,"Ruchi Soya Inds, Laurus Labs Ltd. and Dr. Reddy’s Labs hit their fresh 52-week high during the day.",positive,positive,-2.0920502092050213,negative,6.394849785407719,positive
2020-04-22 13:23:50.000,95.6,95.95,93.0,93.6,1808120.0,"Covid-19: Logistics, shortage of manpower major challenges for pharma industry, says Laurus Labs chief","Disruption of logistics and scarcity of workers are among the major challenges being faced by the pharmaceutical industry in the wake of the coronavrius (Covid-19) pandemic, according to Satyanarayan",neutral,negative,-2.0920502092050213,negative,6.394849785407719,positive
2020-04-24 12:43:00.000,93.2,102.64,91.6,99.16,7873630.0,"Pharma shares rally; Alembic, Sun Pharma, Laurus Labs hit 52-wk highs","Strides Pharma Science, Alkem Laboratories, Ajanta Pharma, Lupin, Ipca Laboratories, Jubilant Life Sciences and FDC were up in the range of 5 per cent to 10 per cent on the BSE",positive,positive,6.394849785407719,positive,2.5892506865437435,positive
2020-04-30 05:07:00.000,104.2,104.43,100.02,102.2,8342930.0,"Important results today: Reliance Industries, Hindustan Unilever, Tech Mahindra","Quarterly results that are expected today include Reliance Industries, Hindustan Unilever, Tech Mahindra, Laurus Labs and Security and Intelligence Services (India) Ltd.",neutral,neutral,-1.919385796545105,negative,-3.466796875000011,negative
2020-04-30 08:24:00.000,104.2,104.43,100.02,102.2,8342930.0,"Board Meetings Today: RIL, HUL, TechM, Just Dial and Laurus Labs","There are corporate actions that often bring material changes to a company, directly affecting stakeholders.",neutral,neutral,-1.919385796545105,negative,-3.466796875000011,negative
2020-04-30 18:08:22.000,104.2,104.43,100.02,102.2,8342930.0,Laurus Labs posts ₹110-cr profit in Q4,"Board recommends stock split, announces dividend",neutral,neutral,-1.919385796545105,negative,-3.466796875000011,negative
2020-04-30 18:53:00.000,104.2,104.43,100.02,102.2,8342930.0,Laurus Labs’ PAT touches Rs 110 crore in Q4,"With higher volumes and new product introduction, our other API (active pharmaceutical ingredient) business segment has posted healthy growth, we do expect this growth rate to continue and improve in the coming quarters,” founder and CEO of Laurus Labs Satyanarayana Chava said.",neutral,positive,-1.919385796545105,negative,-3.466796875000011,negative
2020-05-04 07:15:00.000,102.4,105.0,96.48,98.85,13845970.0,"Analyst Calls: Laurus Labs, Lupin, Rallis India","Nomura has retained buy rating on Lupin and raised target price to Rs 1,049 from Rs 913.",neutral,positive,-3.466796875000011,negative,-1.4976038338658146,negative
2020-05-04 08:26:00.000,102.4,105.0,96.48,98.85,13845970.0,"Buy Laurus Labs, target price Rs 615: Motilal Oswal","The brokerage expects a 23 per cent earnings CAGR, led by a 22 per cent sales CAGR in the FDF/other API segment and a 31 per cent sales CAGR in the Synthesis segment over FY20–22.",neutral,positive,-3.466796875000011,negative,-1.4976038338658146,negative
2020-05-04 10:10:00.000,102.4,105.0,96.48,98.85,13845970.0,"Share Market LIVE: Sensex falls 1,700 points, Nifty at 9,400, UPL, GAIL, Vedanta top losers","Sensex, Nifty Live News Today: Companies that recently announced their March quarter earnings are Reliance Industries, Tech Mahindra, Hindustan Unilever, Apollo Tricoat Tubes, Laurus Labs, Aditya Birla Money, ICICI Lombard, AU Small Finance Bank among ot",neutral,neutral,-3.466796875000011,negative,-1.4976038338658146,negative
2020-05-05 09:29:49.000,100.16,102.34,97.35,98.66,5408850.0,Laurus Labs Q4: Improving product mix and strong execution drive growth,,positive,neutral,-1.4976038338658146,negative,1.102204408817644,positive
2020-05-08 07:30:00.000,93.6,97.71,87.0,88.17,115606200.0,Laurus Labs slips over 8.5% post block deal,"The two large trades took place between Rs441 and Rs445, where buyers and sellers of the trade were not immediately known, the media reports added.",neutral,neutral,-5.801282051282044,negative,-3.623024830699768,negative
2020-05-08 12:57:00.000,93.6,97.71,87.0,88.17,115606200.0,"Laurus Labs under pressure, plunges 10% after multiple block deals","Till 12:44 pm, a combined 34.4 million equity shares, representing 32.2 per cent of total equity of Laurus Labs, changed hands on the BSE and NSE.",negative,neutral,-5.801282051282044,negative,-3.623024830699768,negative
2020-05-08 15:10:00.000,93.6,97.71,87.0,88.17,115606200.0,"D-Street Buzz: 250 stocks hit upper circuit on BSE; volumes of RIL, HUL top the charts","The most active stocks in terms of volumes included Vodafone Idea, Laurus Labs, RBL Bank, State Bank of India, YES Bank, IndusInd Bank, ICICI Bank and Reliance Industries among others.",neutral,neutral,-5.801282051282044,negative,-3.623024830699768,negative
2020-05-08 15:42:00.000,93.6,97.71,87.0,88.17,115606200.0,Laurus Labs tanks 9% post block deals,A report by ET Now stated that Warburg Pincus and Fidelity Capital are likely sellers in the deal.,neutral,neutral,-5.801282051282044,negative,-3.623024830699768,negative
2020-05-08 19:58:00.000,93.6,97.71,87.0,88.17,115606200.0,"Bulk deals: Bluewater Investment, Eight Roads Management sell Laurus Labs shares",Heres who bought what in some of the key bulk deals of the day.,neutral,neutral,-5.801282051282044,negative,-3.623024830699768,negative
2020-05-12 05:30:00.000,85.2,89.48,84.66,88.98,12424415.0,"BRIEF-Laurus Labs Says Eight Roads Management Mauritius, One Other Investor Exit Stake In Co - Investing.com India","The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,4.43661971830986,positive,-2.444444444444448,negative
2020-05-12 10:54:00.000,85.2,89.48,84.66,88.98,12424415.0,Laurus Labs trades firm in an otherwise weak market,"As per BSE filing, Warbug Pincus has reduced its stake in the company to 11.68% from 19.63% on May 8.",negative,negative,4.43661971830986,positive,-2.444444444444448,negative
2020-05-19 05:30:00.000,86.4,91.44,86.01,88.96,10433245.0,BRIEF-Laurus Labs Gets U.S. FDA Approvals For Two ANDAs - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,2.962962962962949,positive,3.8639179903120495,positive
2020-05-19 12:25:00.000,88.77,92.4,88.77,92.2,7271065.0,Laurus Labs rallies 6% after USFDA approval,Laurus Labs is one of the few players in the ARV segment to receive approval for TLE 400 tablets.,positive,neutral,3.8639179903120495,positive,-1.0162162162162136,negative
2020-05-19 14:35:00.000,88.77,92.4,88.77,92.2,7271065.0,Trending stocks: Laurus Labs shares climb 4%,"A total of 70,447 shares changed hands on the counter till 02:31PM (IST).",positive,neutral,3.8639179903120495,positive,-1.0162162162162136,negative
2020-05-19 20:03:45.000,88.77,92.4,88.77,92.2,7271065.0,Laurus Labs gets USFDA nod for HIV drug,Laurus Labs Ltd has received approval from the US Food and Drug Administration (USFDA) for two Abbreviated New Drug Applications (ANDAs ) for Tenofovir/ Lamivudine/ Efavirenz (TLE) for 400 mg and 600,neutral,positive,3.8639179903120495,positive,-1.0162162162162136,negative
2020-05-19 22:37:01.000,88.77,92.4,88.77,92.2,7271065.0,Laurus gets USFDA nod for HIV drug,Laurus Labs on Tuesday said it had received approval of the U.S. Food and Drug Administration (USFDA) for two Abbreviated New Drug Applications under PEPFAR (President’s Emergency Plan for AIDS Relief,neutral,positive,3.8639179903120495,positive,-1.0162162162162136,negative
2020-06-29 16:34:21.000,105.0,105.96,102.85,104.18,10546345.0,Laurus Labs Falls Over 4% On Report Of Block Deals Worth Rs 673 Crore,These block deals were worth Rs 673.08 crore.,neutral,neutral,-0.7809523809523744,neutral,0.6864988558352392,neutral
2020-06-29 16:37:00.000,105.0,105.96,102.85,104.18,10546345.0,Laurus Labs stock tumbles 5% post block deal,"As per media reports, around 1.23 crore shares of the company exchanged hands in a single large trade on the BSE.",negative,neutral,-0.7809523809523744,neutral,0.6864988558352392,neutral
2020-06-29 21:01:00.000,105.0,105.96,102.85,104.18,10546345.0,NSE-BSE bulk deals: Blue Water Investment sells Laurus Labs,Heres who bought and sold what in some of the key bulk deals of the day.,neutral,neutral,-0.7809523809523744,neutral,0.6864988558352392,neutral
2020-06-29 22:00:22.000,105.0,105.96,102.85,104.18,10546345.0,"Bluewater Investment Offloads Rs 632 Crore Stake In Laurus Labs, Titan Europe Sells Shares Worth Rs 146.74 Crore In Wheels India","Bluewater Investment had also sold 85 lakh equity shares in Laurus Labs at Rs 441.26 on May 28, which indicated that it offloaded its entire 19.63 percent stake (2,09,89,596 shares) in the pharma company during the June quarter",neutral,neutral,-0.7809523809523744,neutral,0.6864988558352392,neutral
2020-06-30 08:03:18.000,105.0,105.96,102.85,104.18,10546345.0,"In Pics | Stocks In The News: GAIL India, Laurus Labs, Tata Steel, Tata Power, Force Motors, Raymond, Bharat Dynamics","Orient Refractories, Minda Industries, Central Bank of India, Bharti Airtel, Alphageo India are also in focus today.",neutral,neutral,-0.7809523809523744,neutral,0.6864988558352392,neutral
2020-06-30 11:35:00.000,105.0,105.96,102.85,104.18,10546345.0,Trending stocks: Laurus Labs shares rise nearly 1%,"A total of 73,610 shares changed hands on the counter till 11:32AM (IST).",positive,neutral,-0.7809523809523744,neutral,0.6864988558352392,neutral
2020-07-01 07:48:33.000,104.88,106.08,103.27,105.6,3321890.0,"In Pics | Stocks In The News: ONGC, Hero MotoCorp, RITES, Cyient, Lakshmi Vilas Bank, Marico, Bharti Airtel",Gayatri Projects | Godfrey Phillips | Techno Electric | Kalpataru Power | Marico | APL Apollo Tubes | Cupid | Laurus Labs | Emami Realty | JSPL | Uflex | Goa Carbon | Munjal Auto Industries are also in focus today.,neutral,neutral,0.6864988558352392,neutral,-1.165413533834595,negative
2020-07-13 07:00:00.000,121.49,125.58,119.8,124.66,13097125.0,"Hot Stocks | Some profit-booking likely; Sunteck Realty, Laurus Labs two buy calls for the short-term","Last week, Nifty gyrated in a slender range of merely 160 points. Amid all this, the benchmark index concluded the week with moderate gains of one and half a percent.",neutral,positive,2.609268252531074,positive,-0.8373590982286685,neutral
2020-07-15 11:44:00.000,124.49,127.49,123.16,125.4,5048485.0,"Infosys, HCL Tech, L&T Infotech, Granules, Laurus Labs hit record highs","Reliance Industries, Larsen & Toubro Infotech and Dr Lal Pathlabs from S&P BSE500 index hit record highs today.",positive,positive,0.7309824082255689,neutral,0.7091068440761696,neutral
2020-07-22 11:30:55.000,130.04,135.95,129.8,135.2,7097630.0,"RIL, Muthoot Finance, Granules, JK Cements, Laurus Labs hit record highs","RIL hit a fresh record high of Rs 2,000 mark, up 1.4 per cent in intra-day trade today.",positive,positive,3.96800984312519,positive,5.921294593600597,positive
2020-07-22 14:24:41.000,135.95,144.8,135.5,144.0,10822320.0,"RIL hits Rs 2000 mark; Muthoot Finance, Laurus Labs hit record high","RIL hit a fresh record high of Rs 2,000 mark, up 1.4 per cent in intra-day trade today.",positive,positive,5.921294593600597,positive,0.7628294036061184,neutral
2020-07-30 07:59:00.000,154.0,159.98,152.13,159.9,24454820.0,"Board Meetings Today: HDFC, RIL, Dabur India, Laurus Labs and Max Financial",It makes sense to have a look at the corporate agendas for the days as announced to the stock exchanges.,neutral,neutral,3.8311688311688346,positive,14.181818181818183,positive
2020-07-30 16:18:00.000,165.0,189.0,163.0,188.4,53132670.0,Laurus Labs standalone net profit rises 832.35% in the June 2020 quarter,Sales rise 79.29% to Rs 970.41 crore,positive,positive,14.181818181818183,positive,5.679141585972255,positive
2020-07-30 16:28:00.000,165.0,189.0,163.0,188.4,53132670.0,Laurus Labs consolidated net profit rises 1037.62% in the June 2020 quarter,Sales rise 76.97% to Rs 974.32 crore,positive,positive,14.181818181818183,positive,5.679141585972255,positive
2020-07-30 17:01:00.000,165.0,189.0,163.0,188.4,53132670.0,Laurus Labs Q1 results: Net profit up 11 times to Rs 172 crore,"Revenues from operations were up 77 per cent during the quarter under discussion to Rs 974 crore, a press release said.",positive,positive,14.181818181818183,positive,5.679141585972255,positive
2020-07-30 17:16:03.000,165.0,189.0,163.0,188.4,53132670.0,Laurus Labs’ net up 11 times to Rs 172 cr in Q1,"Laurus Labs Ltd’s net profit for the quarter ended June 30 increased over 11 times to Rs 172 crore against Rs 15 crore during the same period in FY20, the company said.Revenues from operations were up",positive,positive,14.181818181818183,positive,5.679141585972255,positive
2020-07-30 17:54:00.000,165.0,189.0,163.0,188.4,53132670.0,Laurus Labs’ net up 11 times to Rs 172 crore in Q1,"Revenues from operations were up 77 percent during the quarter under discussion to Rs 974 crore, a press release said.",positive,positive,14.181818181818183,positive,5.679141585972255,positive
2020-07-30 23:05:59.000,165.0,189.0,163.0,188.4,53132670.0,Laurus Labs Q1 net surges,"Laurus Labs Q1 net profit surges to ₹171.78 crore Pharmaceutical company Laurus Labs has posted ₹171.78 crore consolidated net profit for the quarter ended June, against ₹15.10 crore in the same peri",positive,positive,14.181818181818183,positive,5.679141585972255,positive
2020-07-31 09:46:00.000,165.0,189.0,163.0,188.4,53132670.0,"Laurus Labs Standalone June 2020 Net Sales at Rs 970.41 crore, up 79.29% Y-o-Y",,positive,neutral,14.181818181818183,positive,5.679141585972255,positive
2020-07-31 12:50:22.000,165.0,189.0,163.0,188.4,53132670.0,Essel Propack Ltd leads gainers in ‘A’ group,"Laurus Labs Ltd, Torrent Pharmaceuticals Ltd, Ipca Laboratories Ltd and Wockhardt Ltd are among the other gainers in the BSEs A group today, 31 July 2020.",positive,neutral,14.181818181818183,positive,5.679141585972255,positive
2020-07-31 13:34:00.000,165.0,189.0,163.0,188.4,53132670.0,Trending stocks: Laurus Labs shares surge over 15%,"A total of 623,838 shares changed hands on the counter till 01:29PM (IST).",positive,neutral,14.181818181818183,positive,5.679141585972255,positive
2020-08-02 16:37:00.000,191.05,215.03,191.0,201.9,67179695.0,Motilal Oswal: Laurus Labs’ Sharp Ramp-Up In Q1 Earnings Led By Finished Dosage Forms And API,Motilal Oswal: Laurus Labs’ Sharp Ramp-Up In Q1 Earnings Led By Finished Dosage Forms And API,neutral,neutral,5.679141585972255,positive,0.3857566765578641,neutral
2020-08-03 12:16:09.000,202.2,204.77,190.4,202.98,24422600.0,Amber Enterprises India Ltd leads gainers in ‘A’ group,"Laurus Labs Ltd, Granules India Ltd, Ratnamani Metals & Tubes Ltd and Dixon Technologies (India) Ltd are among the other gainers in the BSEs A group today, 03 August 2020.",positive,neutral,0.3857566765578641,neutral,0.7094994087504916,neutral
2020-08-03 13:53:00.000,202.2,204.77,190.4,202.98,24422600.0,"Laurus Labs in focus, zooms over 15%; stock hits all-time high","For the April-June, 2020 quarter, Laurus Labs posted consolidated revenue of Rs 974 crore, up 77 per cent year-on-year (YoY)",neutral,positive,0.3857566765578641,neutral,0.7094994087504916,neutral
2020-08-03 14:15:21.000,202.2,204.77,190.4,202.98,24422600.0,This mid-cap pharma stock jumped 15% today; check why Ambit has almost doubled the target price,"API manufacturer, Laurus Labs’ share price surged 15% on Monday after strong April-June quarter results and to club with that, brokerage and research firm Ambit Capital doubled the target price on the stock.",positive,positive,0.3857566765578641,neutral,0.7094994087504916,neutral
2020-08-05 12:43:00.000,206.54,209.34,201.84,207.2,10109745.0,Laurus Labs has gained 3X since we recommended it a year ago. What should you do now?,Laurus Labs’ medium term plan is to increase API manufacturing capacity by 20 percent over 12 months and formulations capacity by 80 percent over 18 months,positive,positive,0.3195506923598318,neutral,-1.5738557058285654,negative
2020-08-07 13:43:00.000,207.77,208.4,202.72,204.5,5457320.0,Buy Laurus Labs; target of Rs 1215: Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1215 in its research report dated August 01, 2020.",neutral,positive,-1.5738557058285654,negative,8.79593810444874,positive
2020-08-11 15:16:28.000,208.8,210.2,200.48,205.17,9140145.0,Laurus Labs Ltd leads losers in ‘A’ group,"Alkem Laboratories Ltd, Caplin Point Laboratories Ltd, CARE Ratings Ltd and Metropolis Healthcare Ltd are among the other losers in the BSEs A group today, 11 August 2020.",positive,negative,-1.7385057471264482,negative,-0.0533954662394957,neutral
2020-08-26 12:46:00.000,231.05,243.8,229.02,238.4,6948345.0,"GMM Pfaudler, Laurus Labs, Birlasoft: 13 BSE500 stocks that doubled in 2020","Going ahead, most analysts expect the mid-and small-cap segments to continue doing well as compared to their large-cap peers, which they feel are now fairly valued",positive,positive,3.1811296256221566,positive,-2.3489932885906017,negative
2020-09-03 10:07:00.000,233.98,242.34,229.65,238.4,4147935.0,Promoters raised stake in over 200 cos in Q1 FY21; 10 stocks rose 100-300%,"10 out of 211 companies rose more than 100 percent so far in the year 2020 that include names like IOL Chemicals, Titan Bio-Tech, Laurus Labs, Anuh Pharma, Astec Lifesciences, and Dishman Carbogen, etc.",positive,positive,1.8890503461834411,positive,1.2887931034482798,positive
2020-09-10 11:47:00.000,245.0,252.99,244.62,248.0,7563600.0,Laurus Labs trades higher for fourth straight day; stock hits record high,The stock has outperformed the market in past four months. It has rallied 171 per cent since June on the back of strong quarterly earnings.,positive,positive,1.2244897959183674,positive,1.4084507042253522,positive
2020-09-17 11:58:00.000,269.88,285.0,268.21,284.65,8344370.0,Laurus Labs hits fresh record high on expectation of strong earnings,Analysts believe Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model,positive,positive,5.472802727137981,positive,3.238950276243092,positive
2020-09-18 10:04:00.000,289.6,304.0,288.0,298.98,16472365.0,"BSE Healthcare index hits record high; Laurus Labs, Dr Reddy’s at new highs","Lupin, Stride Pharma, Neuland Labs, Lincoln Pharma, and Hikal hit their respective 52-week highs on the BSE",positive,positive,3.238950276243092,positive,-5.452127659574479,negative
2020-09-18 11:39:53.000,289.6,304.0,288.0,298.98,16472365.0,Laurus Labs shares up 300% this year; API business drives growth; should you buy?,"In the previous quarter, Laurus Labs recorded its all-time high quarterly net profit of Rs 171 crore, against Rs 15 crore in the same period last year.",positive,negative,3.238950276243092,positive,-5.452127659574479,negative
2020-09-18 14:18:00.000,289.6,304.0,288.0,298.98,16472365.0,Laurus Labs hits record high; adds 26% in ten days,"Laurus Labs jumped 5.74% to Rs 1486.20, extending gains for tenth consecutive session.",positive,positive,3.238950276243092,positive,-5.452127659574479,negative
2020-09-28 10:26:00.000,271.0,292.17,271.0,292.17,10655200.0,Laurus Labs surges 6% as stock to turn ex-date for 1:5 split on Tuesday,"The board has fixed September 30, 2020 as the record date for sub-division of equity shares of the company from existing face value of Rs 10 each to face value of Rs 2 each",positive,neutral,7.811808118081187,positive,-3.177257525083612,negative
2020-09-28 12:04:17.000,299.0,306.95,283.5,289.5,7316124.0,PVR Ltd leads gainers in ‘A’ group,"Laurus Labs Ltd, Metropolis Healthcare Ltd, Shankara Building Products Ltd and Balkrishna Industries Ltd are among the other gainers in the BSEs A group today, 28 September 2020.",positive,neutral,-3.177257525083612,negative,-1.206896551724138,negative
2020-09-28 14:40:00.000,299.0,306.95,283.5,289.5,7316124.0,Laurus Labs hits the roof ahead of record date for stock split,"Laurus Labs hit an upper circuit of 10% at Rs 1459.80 ahead of the companys record date for 5-for-1 stock split on Wednesday, 30 September 2020.",positive,positive,-3.177257525083612,negative,-1.206896551724138,negative
2020-10-01 05:30:00.000,292.0,292.9,277.0,280.7,2240787.0,BRIEF-Laurus Labs’ Unit Laurus Synthesis Inc USA Merges With Laurus Generics Inc USA - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-3.8698630136986334,negative,7.039711191335741,positive
2020-10-05 08:00:00.000,277.0,298.7,268.4,296.5,6069904.0,"Stocks in the news | RIL, Route Mobile, Jindal Steel & Power, Dhanlaxmi Bank, TVS Motor, Jump Networks","Can Fin Homes, CAMS, Future Enterprises, Mukand, Tata Motors, Vedanta, Satin Creditcare Network, Metropolis Healthcare, Indostar Capital Finance, Laurus Labs, SBI and Eicher Motors are also among the stocks in focus today.",neutral,neutral,7.039711191335741,positive,3.692614770459071,positive
2020-10-07 08:27:00.000,312.0,328.0,312.0,327.6,8303741.0,"Trade Spotlight: Thyrocare, Laurus Labs and Advanced Enzyme in focus","Stocks like Thyrocare Technologies rallied nearly 15 percent, while Laurus Labs was up more than 5 percent, and Advanced Enzyme closed with gains of nearly 6 percent were in focus.",neutral,positive,5.000000000000007,positive,2.5045262522631297,positive
2020-10-20 09:01:00.000,333.5,341.25,333.0,336.1,3690739.0,"Despite a sharp runup, these 3 pharma stocks can be good bets","API is a long -term structural play and Divis and Laurus Labs look very good, says Gurmeet Chadha.",positive,positive,0.7796101949025556,neutral,-2.1470588235294152,negative
2020-10-27 16:33:15.000,325.25,329.9,320.05,324.4,4010099.0,Pharma firms Granules and Laurus Labs to invest ₹700 crore in Telangana,Representatives of the firms meet Industries Minister to announce the decision.,neutral,neutral,-0.26133743274405,neutral,4.467084639498433,positive
2020-10-27 18:52:06.000,325.25,329.9,320.05,324.4,4010099.0,Two more drug firms to set shop in Genome Valley,"Our Bureau Drug-makers Granules India Ltd and Laurus Labs have announced independent plans to set up new manufacturing facilities in Genome Valley, Hyderabad.Granules India projectGranules India will",neutral,positive,-0.26133743274405,neutral,4.467084639498433,positive
2020-10-29 04:06:00.000,319.0,337.5,309.0,333.25,11342828.0,Laurus Labs Q2 net profits up 4-fold at Rs242.47cr,"Laurus Labs reported growth of 59.86% in top line sales for the Sep-20 quarter at Rs1,138.84cr. The operating profits for the quarter ended Sep-20 was up 258.82%",positive,positive,4.467084639498433,positive,-5.268656716417904,negative
2020-10-29 05:30:00.000,319.0,337.5,309.0,333.25,11342828.0,BRIEF-Laurus Labs Approved Interim Dividend Of 0.80 Rupees Per Equity Share Of 2 Rupees Each For FY 20-21 - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,4.467084639498433,positive,-5.268656716417904,negative
2020-10-29 16:38:00.000,335.0,344.9,316.5,317.35,11987669.0,Laurus Labs consolidated net profit rises 328.42% in the September 2020 quarter,Sales rise 59.86% to Rs 1138.84 crore,positive,positive,-5.268656716417904,negative,-5.915492957746472,negative
2020-10-29 18:15:00.000,335.0,344.9,316.5,317.35,11987669.0,Laurus Labs reports highest-ever quarterly profit at Rs 242 crore in Q2FY21,"Revenues rose 60 percent YoY to Rs 1,139 crore in Q2FY21, compared to Rs 713.8 crore last year.",positive,positive,-5.268656716417904,negative,-5.915492957746472,negative
2020-10-29 18:16:18.000,335.0,344.9,316.5,317.35,11987669.0,Laurus Labs’ Q2 net zooms to ₹242 crore,"Laurus Labs Ltd’s net profit increased multiple times at ₹242 crore in the second quarter ended September 30, 2020 compared to ₹57 crore in the same period last year.The total revenue of the Hyderaba",neutral,positive,-5.268656716417904,negative,-5.915492957746472,negative
2020-10-29 20:10:00.000,335.0,344.9,316.5,317.35,11987669.0,Laurus Labs Q2 results: Net profit jumps over four-fold to Rs 242.27 cr,"Consolidated revenue from operations of the company stood at Rs 1,138.84 crore for the quarter under consideration. It was Rs 712.42 crore for the same period a year ago, it added.",positive,neutral,-5.268656716417904,negative,-5.915492957746472,negative
2020-10-29 22:56:26.000,335.0,344.9,316.5,317.35,11987669.0,Laurus Labs Q2 net rises manifold,"Drugmaker Laurus Labs has posted a manifold increase in consolidated net profit for the quarter ended September at ₹242.27 crore on the back of a strong performance in the formulations business, espec",neutral,positive,-5.268656716417904,negative,-5.915492957746472,negative
2020-10-30 09:30:00.000,335.0,344.9,316.5,317.35,11987669.0,Laurus Labs hits record high on robust September quarter results,"The companys Ebitda margins improved 1,349 basis points to 32.8 per cent due to better product mix and improved operating leverage",positive,positive,-5.268656716417904,negative,-5.915492957746472,negative
2020-10-30 13:20:00.000,335.0,344.9,316.5,317.35,11987669.0,"With 350% stock gain, drugmaker Laurus Labs seeks to boost capacity",The pharmaceutical sector is the top performer in Indias $2.1 trillion equity market this year after the coronavirus pandemic turned global investors spotlight on health-care companies,positive,positive,-5.268656716417904,negative,-5.915492957746472,negative
2020-10-30 18:04:00.000,335.0,344.9,316.5,317.35,11987669.0,Indian drugmaker Laurus Labs with 350% stock gain seeks to boost capacity,The pharmaceutical sector is the top performer in Indias $2.1 trillion equity market this year after the coronavirus pandemic turned global investors spotlight on health-care companies.,positive,positive,-5.268656716417904,negative,-5.915492957746472,negative
2020-10-30 19:00:20.000,335.0,344.9,316.5,317.35,11987669.0,ICICI Direct: Laurus Labs’ Vertically Integrated Story Panning Out,ICICI Direct: Laurus Labs’ Vertically Integrated Story Panning Out,neutral,neutral,-5.268656716417904,negative,-5.915492957746472,negative
2020-11-01 15:11:45.000,319.5,319.7,298.45,300.6,10592936.0,"Dolat Capital: Laurus Labs’ Strong Beat In Q2, Guidance Maintained","Dolat Capital: Laurus Labs’ Strong Beat In Q2, Guidance Maintained",neutral,neutral,-5.915492957746472,negative,-4.327868852459012,negative
2020-11-01 20:01:00.000,319.5,319.7,298.45,300.6,10592936.0,"Street signs: Market trend turns weak, Laurus Labs stock rises, and more","After a sustained bull run, the markets are expected to enter a turbulent period",neutral,positive,-5.915492957746472,negative,-4.327868852459012,negative
2020-11-02 07:17:00.000,319.5,319.7,298.45,300.6,10592936.0,India’s largest pharma IPO set to hit market,"This will be the largest IPO by a pharmaceutical company in India. The biggest IPO till date in the sector was from Eris Lifesciences, which raised Rs 1,741 crore in 2017. Alkem Laboratories and Laurus Labs raised Rs 1,350 crore each in 2015 and 2016, respectively.",positive,positive,-5.915492957746472,negative,-4.327868852459012,negative
2020-11-02 09:27:46.000,319.5,319.7,298.45,300.6,10592936.0,Laurus Labs: Moves in to next growth orbit; accumulate,Laurus Labs has gained 3.6X since we recommended it in July 2019. What should you do now?,neutral,positive,-5.915492957746472,negative,-4.327868852459012,negative
2020-11-02 12:54:00.000,305.0,305.35,287.35,291.8,7291110.0,Buy Laurus Labs; target of Rs 400: Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 400 in its research report dated October 30, 2020.",neutral,positive,-4.327868852459012,negative,-5.256849315068501,negative
2020-11-02 15:12:00.000,305.0,305.35,287.35,291.8,7291110.0,Buy Laurus Labs; target of Rs 385: Sharekhan,"Sharekhan is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 385 in its research report dated October 30, 2020.",neutral,positive,-4.327868852459012,negative,-5.256849315068501,negative
2020-11-02 18:45:00.000,305.0,305.35,287.35,291.8,7291110.0,"Laurus Labs Standalone September 2020 Net Sales at Rs 1,127.30 crore, up 59.71% Y-o-Y",,positive,neutral,-4.327868852459012,negative,-5.256849315068501,negative
2020-11-03 13:41:35.000,292.0,296.3,270.05,276.65,9326916.0,"Down 10% in three days, could Laurus Labs share price be turning a corner now?",API has been the story so far in mid-cap pharma firms like Laurus that have the potential to help India take a piece of the pie that China has been eating almost entirely by itself so far.,positive,neutral,-5.256849315068501,negative,0.2489774141917288,neutral
2020-11-03 16:57:00.000,292.0,296.3,270.05,276.65,9326916.0,Accumulate Laurus Labs; target of Rs 400: Dolat Capital Market,"Dolat Capital Market recommended accumulate rating on Laurus Labs with a target price of Rs 400 in its research report dated November 01, 2020.",neutral,positive,-5.256849315068501,negative,0.2489774141917288,neutral
2020-11-04 14:24:00.000,281.15,290.0,279.5,281.85,6301789.0,"Laurus Labs extends fall for fourth straight day, dips 21% from record high",The companys profit after tax (PAT) was up 328 per cent year-on-year (YoY) at Rs 242 crore.,negative,positive,0.2489774141917288,neutral,-1.7033356990773636,negative
2020-11-04 15:04:05.000,281.15,290.0,279.5,281.85,6301789.0,Equitas Holdings Ltd leads losers in ‘A’ group,"Godrej Properties Ltd, Suzlon Energy Ltd, Laurus Labs Ltd and Meghmani Organics Ltd are among the other losers in the BSEs A group today, 04 November 2020.",negative,negative,0.2489774141917288,neutral,-1.7033356990773636,negative
2020-11-04 21:48:00.000,281.15,290.0,279.5,281.85,6301789.0,Buy Laurus Labs; target of Rs 390: ICICI Direct,"ICICI Direct is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 390 in its research report dated October 30, 2020.",neutral,positive,0.2489774141917288,neutral,-1.7033356990773636,negative
2020-11-10 11:31:00.000,263.1,275.4,254.2,260.0,9025954.0,Nifty hits fresh all-time high; these 12 stocks more than doubled from March lows,"JB Chemicals, Tata Comm, Dixon Technologies, Laurus Labs and Birlasoft among 12 stocks which rose over 100 percent since March",positive,positive,-1.1782592170277546,negative,12.976190476190473,positive
2020-11-12 08:54:00.000,284.95,294.9,284.0,288.95,6211083.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term","Ashwani Gujral of ashwanigujral.com recommends buying Apollo Hospitals with a stop loss of Rs 2,170, target at Rs 2,300 and Laurus Labs with a stop loss of Rs 276, target at Rs 292.",neutral,neutral,1.403755044744692,positive,-1.647018030513176,negative
2020-11-13 08:08:00.000,288.4,292.5,282.1,283.65,2708750.0,"Adani Green Energy, Laurus Labs among top value creators in Samvat 2076","Meanwhile, Dr Reddys Laboratories, Cipla, Infosys, HCL Technologies were up between 25 per cent and 75 per cent.",neutral,positive,-1.647018030513176,negative,1.010452961672466,positive
2020-11-19 07:19:00.000,271.3,275.25,267.55,268.75,3552688.0,"Top bets! Laurus, IndiaMART see biggest jump in consensus price target","For instance, the consensus target price for Laurus Labs has increased by 99.8 per cent to Rs 361.86 after the company registered a four-fold jump in consolidated net profit to Rs 242.3 crore in the September quarter.",positive,positive,-0.9399189089568784,negative,4.797184663826631,positive
2020-11-23 14:16:00.000,292.9,294.9,286.0,289.9,2855015.0,2 pharma stocks that could give good returns,"Divis Lab and Laurus Labs are two stocks that could be expected to do well, says Kunj Bansal.",positive,positive,-1.0242403550699897,negative,-2.4143835616438394,negative
2020-11-25 05:30:00.000,292.0,292.15,282.55,284.95,2181124.0,BRIEF-Laurus Labs Ltd - To Acquire 72.55% Stake In Richcore Lifesciences Pvt Ltd - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-2.4143835616438394,negative,-1.0338983050847497,negative
2020-11-25 18:15:00.000,295.0,298.8,289.3,291.95,4537989.0,Laurus Labs to acquire 72.55% stake in Richcore Lifesciences,"This acquisition marks the Company entry into the broader biologics and biotechnology segments. Post this acquisition, Richcore shall become a Subsidiary Company of the Company and the Company will drive scale and operations at Richcore to enable",neutral,positive,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-25 18:15:35.000,295.0,298.8,289.3,291.95,4537989.0,Laurus Labs to buy 72.55% stake in Richcore Life Sciences,"Laurus Labs has signed a definitive agreement to acquire a 72.55 per cent stake in Bengaluru-based Richcore Lifesciences Pvt Ltd for ₹247 crore.“We are very excited about this acquisition, as this giv",neutral,positive,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-25 21:22:00.000,295.0,298.8,289.3,291.95,4537989.0,Laurus Labs acquires biotech company Richcore Lifesciences,"Laurus is one of India’s leading manufacturers of active pharmaceutical ingredients (API) for Anti-Retroviral (ARV), Oncology, Cardiovascular, Anti-Diabetics, Anti-Asthma and Gastroenterology medicines, besides pharmaceutical contract manufacturing servic",neutral,neutral,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-25 23:04:00.000,295.0,298.8,289.3,291.95,4537989.0,Laurus Labs inks deal to buy majority stake in Richcore for Rs 247 crore,"Following the successful closure of thetransaction, Richcore will be renamed as Laurus Bio Pvt Ltd, it added",neutral,neutral,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 07:34:00.000,295.0,298.8,289.3,291.95,4537989.0,"Stocks in the news | Lakshmi Vilas Bank, Future Consumer, Adani Green Energy, HFCL, Laurus Labs","Tanla Platforms, PVR, Vikas EcoTech, Siemens, MT Educare, Texmaco Rail & Engineering, Fine Organic Industries, JTL Infra, are also among the stocks in focus today.",neutral,neutral,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 08:29:03.000,295.0,298.8,289.3,291.95,4537989.0,"Stocks in focus: HDFC Bank, Laurus Labs, Lakshmi Vilas Bank, Larsen & Toubro","On the charts, 12850 and 12550 levels act as major support for the index, while on the higher side, 12980 and 13050 would be the hurdles.",neutral,positive,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 08:32:12.000,295.0,298.8,289.3,291.95,4537989.0,"Stocks To Watch: Lakshmi Vilas Bank, Laurus Labs, Siemens, TCS, Vakrangee",Here are the stocks to watch in trade today.,neutral,neutral,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 08:42:00.000,295.0,298.8,289.3,291.95,4537989.0,"Siemens, Shriram Transport Finance, Laurus Labs in focus","Siemens registered a revenue from continuing operations of Rs 3,422 crore, a 9.2% decrease over the corresponding quarter of the previous year. Profit from operations from continuing operations improved from 10% to 11.4% of revenue for the",neutral,positive,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 08:53:00.000,295.0,298.8,289.3,291.95,4537989.0,"Stocks to watch: Laurus Labs, Fine Organics Ind, PVR, Union Bank of India",Heres a list of stocks that may trade actively in todays session.,neutral,neutral,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 09:18:27.000,295.0,298.8,289.3,291.95,4537989.0,From Lakshmi Vilas Bank to Laurus Labs: Stocks in News Today,"The 30-share BSE index on Wednesday plunged 694.92 points, ending at 43,828.10. On the other hand, the broader NSE Nifty also went down 196.75 points, reaching 12,858.40.",neutral,negative,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 09:23:00.000,295.0,298.8,289.3,291.95,4537989.0,"Laurus Labs steps in broader biologics and biotechnology segment, to buy majority stake in Richcore Lifesciences","On the closure of the transaction, Richcore will be renamed to Laurus Bio Pvt Ltd.",neutral,neutral,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 09:27:00.000,295.0,298.8,289.3,291.95,4537989.0,Laurus Labs gains 5% on acquisition of Richcore Lifesciences,Laurus Labs has signed a definitive agreement to acquire 72.55 per cent of Richcores shares from Eight Roads Ventures and VenturEast for a value of Rs. 246.7 crore,positive,positive,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 09:31:00.000,295.0,298.8,289.3,291.95,4537989.0,"Top stocks in focus: Siemens, Laurus Labs & more","Here are the top stocks that are likely to be in focus in today’s trading. Siemens, Laurus Labs, LVB, Indigo, Astral Poly.",neutral,neutral,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 10:43:00.000,295.0,298.8,289.3,291.95,4537989.0,Laurus Labs share rises 5% after firm buys 73% stake in Richcore Lifesciences,Laurus Labs share rose 5% in early trade on Thursday after the pharma firm inked a definitive agreement to acquire 72.55% of Richcore’s stake from Eight Roads Ventures and VenturEast for Rs 246.67 crore.,positive,positive,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 10:43:00.000,295.0,298.8,289.3,291.95,4537989.0,"Stocks in news: Future Retail, DHFL, Siemens, AstraZeneca Pharma, Ashok Leyland, Laurus Labs","Stocks to watch today on November 26: Future Retail, DHFL, Siemens, AstraZeneca Pharma, Ashok Leyland, Laurus Labs among others are the top stocks to watch out for in Thursday’s trading session",neutral,neutral,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 11:14:00.000,295.0,298.8,289.3,291.95,4537989.0,Laurus Labs rallies on buying 73% stake in Biotech firm for Rs 247 cr,Laurus Labs rose 2.65% to Rs 292.60 after the company said it signed a definitive agreement to acquire a majority stake in Richcore Lifesciences.,positive,positive,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 11:27:00.000,295.0,298.8,289.3,291.95,4537989.0,Laurus Labs jumps 4% on acquisition of Richcore Lifesciences,"​The stock has rallied 10 per cent over the last one week, and has jumped more than 300 per cent year-to-date.",positive,positive,-1.0338983050847497,negative,7.978814283273543,positive
2020-11-26 12:50:00.000,292.65,321.0,291.0,316.0,10640576.0,"Top stocks in focus: Lakshmi Vilas Bank, Laurus Labs, Astral Poly Technik, Siemens, Fine Organic Industries",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,7.978814283273543,positive,0.7498828308076791,neutral
2020-11-26 19:24:00.000,292.65,321.0,291.0,316.0,10640576.0,Laurus Labs says Richcore buy will help it become a leading biotech contract manufacturer,"In an interview to Moneycontrol, Satyanarayana Chava, CEO of Laurus Labs, said Richore acquisition will help them leapfrog in biotech which is considered to be capital intensive with high gestation periods for breakeven.",positive,positive,7.978814283273543,positive,0.7498828308076791,neutral
2020-11-26 21:02:03.000,292.65,321.0,291.0,316.0,10640576.0,A promising deal: Laurus Labs acquisition of Richcore Lifesciences,"The buy will give Laurus Labs access to the biotech space, and captive fermentation capacities.",positive,positive,7.978814283273543,positive,0.7498828308076791,neutral
2020-11-27 10:22:00.000,292.65,321.0,291.0,316.0,10640576.0,Laurus Labs gains 7% in two days on acquisition of Richcore Lifesciences,Motilal Oswal Securities maintains buy rating on Laurus Labs with target price of Rs 410 per share,positive,positive,7.978814283273543,positive,0.7498828308076791,neutral
2020-11-27 10:53:41.000,292.65,321.0,291.0,316.0,10640576.0,Multibagger Stock: Laurus Labs looks to diversify with new acquisition; should you ‘buy’ or ‘sell’?,Would this acquisition help Laurus Labs resume its sharp upward march that we have seen so far this year? Shares of Laurus Labs have zoomed 357% since the end of March this year.,neutral,positive,7.978814283273543,positive,0.7498828308076791,neutral
2020-11-27 16:57:00.000,292.65,321.0,291.0,316.0,10640576.0,Rs 70 to Rs 316: This stock has turned into a multibagger in one year,"Share of Laurus Labs has delivered strong returns to investors in last one year. Laurus Labs share price stood at Rs 70 an year ago and closed at Rs 316.15 on November 27, translating into gains of 347% during the period. In comparison, Sensex gained 7.43",positive,positive,7.978814283273543,positive,0.7498828308076791,neutral
2020-11-27 23:54:59.000,292.65,321.0,291.0,316.0,10640576.0,Analyst Corner: Laurus Labs’ strength is adding new revenue streams,"Laurus has announced acquisition of 72.55% stake in Richcore Lifesciences, a Bangalore-based company for a consideration of Rs 2.5 bn, valuing Richcore at Rs 3.4 bn.",positive,neutral,7.978814283273543,positive,0.7498828308076791,neutral
2020-12-02 09:45:59.000,324.4,325.0,317.0,320.0,3144960.0,Laurus Labs: Foray into biotech adds new lever of growth; accumulate,Efforts to diversify will open up new opportunities for Laurus Labs and make it move towards a higher-margin trajectory,positive,positive,-1.3563501849568365,negative,-0.8217054263565822,neutral
2020-12-02 11:09:58.000,324.4,325.0,317.0,320.0,3144960.0,"Being FII favourites, these 11 stocks have gained over 100% in 2020 so far","Some stocks like Adani Green Energy, Aarti Drugs, and Laurus Labs have gained over 300 percent in 2020 so far",positive,positive,-1.3563501849568365,negative,-0.8217054263565822,neutral
2020-12-02 11:26:36.000,324.4,325.0,317.0,320.0,3144960.0,10 stocks on brokerages’ radar for double-digit returns,"Laurus Labs, Infosys, Tech Mahindra and IndusInd Bank are among the 10 stocks brokerages are betting on for up to 29 percent upside.",neutral,positive,-1.3563501849568365,negative,-0.8217054263565822,neutral
2020-12-03 05:30:00.000,322.5,322.8,318.0,319.85,1972612.0,Why Laurus Labs Zoomed 365% in Eight Months - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.8217054263565822,neutral,3.499999999999996,positive
2020-12-04 14:35:00.000,320.0,334.5,317.0,331.2,5392629.0,"BSE Healthcare index hits new high; Sun Pharma, Laurus Labs gain up to 5%","Sun Pharmaceutical Industries hit afresh 52-week high of Rs 568.50, up nearly 4 per cent in the intra-day trade today. It has surged 11 per cent in the past four trading days on the BSE",positive,positive,3.499999999999996,positive,-0.7478312892611426,neutral
2020-12-09 08:50:00.000,335.0,335.85,326.1,328.7,1735561.0,3 pharma stocks that should be bought on dips,"Dr Reddys, Sun Pharma and in terms of API business, Laurus Labs are very promising and can be bought on dips, says Yogesh Mehta.",neutral,positive,-1.8805970149253763,negative,0.3353658536585435,neutral
2020-12-16 11:28:14.000,329.4,344.9,327.65,338.4,6286480.0,Slideshow | Brokerages Bet On These 7 Stocks For An Upside Of Up To 69%,"Gail India, NRB Bearings, Capacite Infraprojects and Laurus Labs are among the stocks for which brokerages have maintained a ‘buy’ rating.",neutral,neutral,2.7322404371584703,positive,0.5278592375366602,neutral
2020-12-17 09:23:00.000,341.0,352.25,339.0,342.8,4188011.0,Pharma and IT stocks Kunj Bansal is betting on,"Persistent Systems in midcap IT and Divis Labs and Laurus Labs in pharma are good bets, says Kunj Bansal.",neutral,positive,0.5278592375366602,neutral,3.454810495626829,positive
2020-12-23 11:35:00.000,339.35,346.9,337.7,343.0,2613433.0,Laurus Labs allots 6.07 lakh equity shares under ESOS,Powered by Capital Market - Live News,neutral,neutral,1.0755856785030138,positive,0.3458213256484117,neutral
2020-12-23 13:15:04.000,347.0,354.4,346.0,348.2,2522322.0,Buy Laurus Labs: Target Of Rs 410: Sharekhan,"Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 410 in its research report dated December 22, 2020.",neutral,positive,0.3458213256484117,neutral,-1.3064470320931618,negative
2020-12-29 12:50:00.000,348.1,353.4,341.1,353.0,1517404.0,"Out of 10 biggest small investor bets, only one shone in 2020; 9 eroded wealth",All stocks but Laurus Labs delivered poor returns: seven of them ended up eroding up to 77 per cent of investor wealth; two delivered a tepid return of 3 per cent each.,positive,positive,1.4076414823326564,positive,0.3265190232822357,neutral
2021-01-12 07:27:25.000,351.0,355.65,349.05,353.0,1048352.0,"Stocks In The News | GAIL, Tata Motors, Burger King India, Emami, InterGlobe Aviation","Force Motors, Wardwizard Innovations & Mobility, Emami, Cummins India, Dishman Carbogen Amcis, Laurus Labs, Inox Leisure, Kesoram Industries, InterGlobe Aviation, are also among the stocks in focus today.",neutral,neutral,0.5698005698005698,neutral,-1.558515160102012,negative
2021-01-12 09:22:00.000,351.0,355.65,349.05,353.0,1048352.0,Laurus Labs arm incorporates wholly-owned unit,"The pharmaceutical ingredients maker said that its wholly-owned subsidiary, Laurus Synthesis, incorporated a subsidiary by the name of Laurus Ingredients with effect from 9 January 2021.",neutral,neutral,0.5698005698005698,neutral,-1.558515160102012,negative
2021-01-12 15:32:00.000,352.9,355.25,343.1,347.4,1530486.0,Laurus Labs subsidiary incorporates Laurus Ingredients; stock gains 1%,Laurus Synthesis has incorporated wholly-owned subsidiary with effect from January 9. Laurus Ingredients shall be a stepdown subsidiary for Laurus Labs.,positive,neutral,-1.558515160102012,negative,5.488850771869636,positive
2021-01-20 18:14:38.000,375.7,379.75,366.4,372.0,2361549.0,Laurus Labs completes acquisition of 72.55% stake in Richcore Lifesciences,"Laurus Labs Ltd has completed the acquisition of 72.55 per cent stake in Richcore Lifesciences Private Ltd.In November last year, Hyderabad based Laurus inked a definitive agreements with the sellers,",positive,positive,-0.9848283204684558,negative,-0.2691790040376851,neutral
2021-01-21 07:33:36.000,375.7,379.75,366.4,372.0,2361549.0,"Stocks In The News | L&T Technology, Axis Bank, Bajaj Finance, Kirloskar Oil Engines, Laurus Labs","Aditya Birla Fashion, Havells India, GMM Pfaudler, Phillips Carbon Black, Zodiac Clothing, VST Industries, HDFC AMC, Everest Industries, Indo Rama Synthetics, are also among the stocks in focus today.",neutral,neutral,-0.9848283204684558,negative,-0.2691790040376851,neutral
2021-01-21 08:31:20.000,375.7,379.75,366.4,372.0,2361549.0,"Stocks To Watch: Asian Paints, Axis Bank, Bajaj Auto, Laurus Labs, Sagar Cement",Here are the stocks to watch in trade today,neutral,neutral,-0.9848283204684558,negative,-0.2691790040376851,neutral
2021-01-21 12:01:00.000,371.5,375.0,366.85,370.5,2210091.0,Laurus Labs completes acquisition of 72.55% stake in Richcore,"The company on January 20, 2021, has completed the transaction as per the definitive agreements with sellers.",positive,neutral,-0.2691790040376851,neutral,1.3336889837289945,positive
2021-01-28 05:30:00.000,363.0,366.6,350.1,358.0,7165077.0,BRIEF-India’s Laurus Labs Dec-Qtr Consol Net PAT Rises,BRIEF-India’s Laurus Labs Dec-Qtr Consol Net PAT Rises,neutral,neutral,-1.3774104683195594,negative,-5.737704918032787,negative
2021-01-28 07:40:00.000,363.0,366.6,350.1,358.0,7165077.0,"Stocks in the news: Axis Bank, Maruti Suzuki, IRCTC, Lupin, HUL and IndiGo","Laurus Labs, Aarti Industries, AU SFB and Shriram Transport are among companies which will announce their December quarter results on Thursday.",neutral,neutral,-1.3774104683195594,negative,-5.737704918032787,negative
2021-01-28 16:45:49.000,366.0,373.65,340.0,345.0,5007349.0,Laurus Labs Q3 net profit zooms to ₹273 cr,Laurus Labs Ltd posted a record increase in net profit at ₹273 crore in the third quarter ended December 2020 compared to ₹73 crore in the same period in the previous fiscal.The company’s revenue gre,neutral,positive,-5.737704918032787,negative,1.66545981173063,positive
2021-01-28 17:28:00.000,366.0,373.65,340.0,345.0,5007349.0,Laurus Labs Q3 results: Net profit zooms nearly 4-fold to Rs 273 cr,"The company had posted a net profit of Rs 73.47 crore for the corresponding period of the previous fiscal, Laurus Labs said in a filing to BSE.",neutral,positive,-5.737704918032787,negative,1.66545981173063,positive
2021-01-28 17:35:00.000,366.0,373.65,340.0,345.0,5007349.0,Laurus Labs consolidated net profit rises 271.33% in the December 2020 quarter,Sales rise 76.60% to Rs 1288.42 crore,positive,positive,-5.737704918032787,negative,1.66545981173063,positive
2021-01-28 21:22:17.000,366.0,373.65,340.0,345.0,5007349.0,Laurus Labs Q3 net up four fold,"Drugmaker Laurus Labs has reported ₹272.85 crore consolidated net profit for the quarter ended December, which is nearly a four fold increase from the ₹73.47 crore posted in the corresponding period o",positive,positive,-5.737704918032787,negative,1.66545981173063,positive
2021-01-29 08:43:38.000,366.0,373.65,340.0,345.0,5007349.0,"Stocks in focus: Bharti Airtel, Maruti Suzuki, Laurus Labs, Vedanta, Tech Mahindra","On the charts, a small positive candle was formed with gap down opening with upper and lower shadow, according to Nagaraj Shetti, Technical Research Analyst, HDFC Securities.",neutral,neutral,-5.737704918032787,negative,1.66545981173063,positive
2021-01-29 09:22:57.000,366.0,373.65,340.0,345.0,5007349.0,"Laurus Labs Standalone December 2020 Net Sales At Rs 1,272.27 Crore, Up 76.46% Y-o-Y",,neutral,neutral,-5.737704918032787,negative,1.66545981173063,positive
2021-01-29 13:23:00.000,366.0,373.65,340.0,345.0,5007349.0,"We are cautiously investing to increase capacities: Satyanarayana Chava, Laurus Labs","Pharma company Laurus Labs on Thursday reported a nearly 4-fold jump in its consolidated net profit to Rs 272.85 crore for the quarter ended in December mainly on account of robust sales. Satyanarayana Chava, Founder & CEO, Laurus Labs, in conversation with ET NOW on how the Q3 growth momentum is ex…",positive,positive,-5.737704918032787,negative,1.66545981173063,positive
2021-01-29 16:57:00.000,366.0,373.65,340.0,345.0,5007349.0,"Laurus Labs reports revenue growth of 76%, PAT rises whopping 274% in Q3 FY21",The company declared an interim dividend of Rs0.40 per share.,positive,neutral,-5.737704918032787,negative,1.66545981173063,positive
2021-01-31 16:34:00.000,345.25,354.65,333.05,351.0,4433943.0,Laurus Labs Q3 Review - Vertically Integrated Story Panning Out: ICICI Direct,Laurus Labs Q3 Review - Vertically Integrated Story Panning Out: ICICI Direct,neutral,neutral,1.66545981173063,positive,-2.104519774011296,negative
2021-02-03 20:47:15.000,342.95,347.7,341.2,347.0,2380208.0,Buy Laurus Labs; Target Of Rs 470: Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 470 in its research report dated January 30, 2021.",neutral,positive,1.1809301647470511,positive,-1.7790530846484902,negative
2021-02-04 11:45:28.000,342.95,347.7,341.2,347.0,2380208.0,Laurus Labs: Diversification 2.0 Is Unfolding,"Laurus lab’s earnings growth is likely to maintain a strong momentum even beyond the forecast period on new capacity addition and foray into high growth areas of biotech, CDMO and oncology APIs",neutral,positive,1.1809301647470511,positive,-1.7790530846484902,negative
2021-02-05 19:14:41.000,348.5,349.65,341.1,342.3,1904114.0,Buy Laurus Labs; Target Of Rs 440: ICICI Direct,"ICICI Direct is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 440 in its research report dated January 30, 2021.",neutral,positive,-1.7790530846484902,negative,3.8121466879257966,positive
2021-02-08 20:54:36.000,360.0,365.0,358.0,362.0,3461167.0,Buy Laurus Labs; Target Of Rs 410: Sharekhan,"Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 410 in its research report dated January 29, 2021.",neutral,positive,0.5555555555555556,neutral,-0.4012730040127426,neutral
2021-02-09 07:15:19.000,360.0,365.0,358.0,362.0,3461167.0,"Hot Stocks | Laurus Labs, Indian Hotels And Maithan Alloys Could Give 8-10% Return In Short Term","Immediate target for Nifty is seen at 15,470, which happens to be 161.8 percent retracement of the entire fall seen from January 2020 to March 2020.",neutral,positive,0.5555555555555556,neutral,-0.4012730040127426,neutral
2021-02-09 23:48:03.000,361.35,363.6,355.5,359.9,1749669.0,Buy Laurus Labs; Target Of Rs 426: Dolat Capital Market,"Dolat Capital Market is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 426 in its research report dated January 31, 2021.",neutral,positive,-0.4012730040127426,neutral,2.793296089385475,positive
2021-02-10 10:18:40.000,361.35,363.6,355.5,359.9,1749669.0,FIIs Reduce Stake In 40 Largecap Stocks In Q3 FY21; Time To Book Profits?,"Among these, four largecaps have rallied more than 100 percent. These include JSW Steel, Tata Motors, Adani Enterprises, and Laurus Labs. Meanwhile, nine stocks rose 50-100 percent since June 30, data showed.",neutral,positive,-0.4012730040127426,neutral,2.793296089385475,positive
2021-02-10 18:23:00.000,358.0,369.7,356.2,368.0,3479145.0,Laurus Labs wins Golden Peacock Award for Excellence in Corporate Governance 2020,Powered by Capital Market - Live News,positive,neutral,2.793296089385475,positive,1.91082802547771,positive
2021-02-10 19:40:00.000,358.0,369.7,356.2,368.0,3479145.0,Laurus Labs hikes its stake in Richcore Lifesciences (subsidiary),"Further, 7,765 share warrants, which shall be convertible into equal number of equity shares
within a period of 3 years, have been issued by the Board of Directors of Richcore to the
Promoters of Richcore in its meeting held on 10 February 2021.",neutral,neutral,2.793296089385475,positive,1.91082802547771,positive
2021-02-11 11:57:24.000,358.0,369.7,356.2,368.0,3479145.0,Laurus Labs’ Management Shares Outlook For Q4 & Beyond,Laurus Labs’ Management Shares Outlook For Q4 & Beyond,neutral,neutral,2.793296089385475,positive,1.91082802547771,positive
2021-02-12 10:00:30.000,368.95,380.0,365.9,376.0,5274837.0,"Laurus Labs Will Continue To Maintain Margin At 30%, Says CEO","“In four-five years people will think we’re a well diversified company,” CEO Chava said.",neutral,positive,1.91082802547771,positive,-2.407407407407413,negative
2021-02-23 10:41:00.000,358.5,364.55,358.15,363.95,1659400.0,"Telangana’s aiming for $100 billion life sciences exports by 2030, says Minister KT Rama Rao","Some of the companies that announced expansions and investments include Switzerland-based Ferring Pharmaceuticals, Canadian firm Jamp Pharmaceutical, Syngene, GVK Bio, Granules India, Laurus Labs and Sai Lifesciences.",neutral,neutral,1.520223152022312,positive,-0.837912087912091,neutral
2021-03-04 05:30:00.000,362.85,382.65,362.5,368.7,11096564.0,BRIEF-Laurus Labs Says Promoters Set To Release Pledge Of Co’s Shares,BRIEF-Laurus Labs Says Promoters Set To Release Pledge Of Co’s Shares,neutral,neutral,1.6122364613476547,positive,-4.959459459459466,negative
2021-03-04 21:48:50.000,370.0,374.25,348.5,351.65,4479097.0,Two promoters of Laurus Labs sell shares to revoke pledge,"Laurus Labs on Thursday said that Satyanarayana Chava, its Founder Promoter, CEO &amp; ED, sold 52 lakh shares of the company. The shares were sold on Thursday at an average price of ₹368.59, ag",neutral,neutral,-4.959459459459466,negative,-2.9859154929577527,negative
2021-03-04 22:54:02.000,370.0,374.25,348.5,351.65,4479097.0,Laurus Lab promoters sell 70 lakh shares,"Laurus Labs founder and CEO Satyanarayana Chava on Thursday sold 52 lakh equity shares of the company in the stock market at an average price of ₹368.59 per share, aggregating to ₹191.67 crore. His wi",neutral,neutral,-4.959459459459466,negative,-2.9859154929577527,negative
2021-03-05 07:53:02.000,370.0,374.25,348.5,351.65,4479097.0,"Buzzing Stocks | Wipro, Unichem Labs, Balrampur Chini Mills, Laurus Labs, Jagran Prakashan, GG Engineering, Asian Granito India","Heranba Industries, Unichem Labs, B L Kashyap and Sons, Balrampur Chini Mills, Igarashi Motors India, Nitin Spinners, RCL Retail, ISGEC Heavy Engineering are also among the stocks in focus today.",neutral,neutral,-4.959459459459466,negative,-2.9859154929577527,negative
2021-03-05 13:08:00.000,370.0,374.25,348.5,351.65,4479097.0,"Top stocks in focus: Wipro, Heranba Industries, Unichem Labs, Laurus Labs, ISGEC Heavy Engineering",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,-4.959459459459466,negative,-2.9859154929577527,negative
2021-03-05 14:23:00.000,370.0,374.25,348.5,351.65,4479097.0,Laurus Labs falls 5% as promoters sell 1.3% stake in company,Laurus Labs said the significant part of the above amount shall be utilized to release the pledge on their equity shares of the company,neutral,neutral,-4.959459459459466,negative,-2.9859154929577527,negative
2021-03-05 17:46:28.000,370.0,374.25,348.5,351.65,4479097.0,Laurus Labs promoters sell 70 lakh shares worth ₹258 crore to revoke pledge,"‘Significant part of the above amount shall be utilized to release the pledge on their equity shares of the company,’ Laurus Labs said",neutral,neutral,-4.959459459459466,negative,-2.9859154929577527,negative
2021-03-05 18:01:00.000,370.0,374.25,348.5,351.65,4479097.0,Laurus Labs promoters sold shares worth Rs257.71cr to release pledge; Stock dips 3%,"Notably, these promoters have purchased around 3% of the then paid-up capital of the Company in the year 2018.",neutral,neutral,-4.959459459459466,negative,-2.9859154929577527,negative
2021-03-05 18:15:28.000,370.0,374.25,348.5,351.65,4479097.0,Laurus Labs Shares Decline Over 4% After Promoters Offload Total 1.3% Shareholding,"On BSE, the scrip ended at Rs 351.3, down 4.63 per cent over previous close.",neutral,negative,-4.959459459459466,negative,-2.9859154929577527,negative
2021-03-12 08:57:55.000,367.55,373.7,361.0,361.5,4382987.0,Buy Laurus Labs: Target Of Rs 450: Sharekhan,"Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 450 in its research report dated March 10, 2021.",neutral,positive,-1.6460345531220273,negative,-2.8688524590163933,negative
2021-03-19 22:31:15.000,340.0,364.0,334.0,359.95,4617856.0,"IBLA 2021: Nestle Bags Outstanding Company of the Year, Laurus Labs Wins Most Promising Company","At the 16th edition of the India Business Leaders Awards, 2021, Nestle was judged as the Outstanding Company of the Year while Laurus Labs bagged the award in the Most Promising Company of the Year category.",neutral,neutral,5.867647058823526,positive,0.2495840266222898,neutral
2021-03-23 14:25:00.000,362.0,365.0,354.95,356.35,2067105.0,Should you buy these financials on dips?,"Deven Choksey says he is looking to buy HFCs, Bajaj Finance among financials and Laurus Labs and Divi’s among pharma stocks on corrections.",neutral,neutral,-1.5607734806629772,negative,-2.5140449438202217,negative
2021-03-24 09:21:00.000,362.0,365.0,354.95,356.35,2067105.0,CARE upgrades rating outlook on Laurus Labs banking facilities,The rating was reaffirmed at AA- on long-term bank facilities and CARE A1+ on short-term facilities.,positive,positive,-1.5607734806629772,negative,-2.5140449438202217,negative
2021-04-01 12:20:00.000,362.0,369.05,361.5,365.45,1616800.0,"Dixon Tech, Adani Green: How to trade multi-baggers of FY21 in new fiscal","Hindustan Copper, Aarti Drugs, Dixon Technology, APL Apollo Tubes, Laurus Labs and Affle India, meanwhile, zoomed over 400 per cent during FY21",neutral,neutral,0.953038674033146,positive,1.6304347826086956,positive
2021-04-06 07:15:23.000,377.4,402.8,376.1,397.0,11226467.0,"Hot Stocks | Gujarat Fluorochemicals, Laurus Labs, Mastek Can Give Up To 12% Return In Short Term","Nifty is likely to find immediate resistance in the range of 14,700-14,750 where 5, 10 and 20-day exponential moving averages are placed. It could aim for 14,883-15,000 if it closes above 14,750.",neutral,neutral,5.193428722840494,positive,3.784516765285988,positive
2021-04-06 09:53:00.000,377.4,402.8,376.1,397.0,11226467.0,"Laurus Labs rallies 6%, hits record high on heavy volume","The pharmaceutical company’s stock surpassed its previous high of Rs 386, touched on January 25, 2021",positive,positive,5.193428722840494,positive,3.784516765285988,positive
2021-04-06 13:15:00.000,405.6,426.65,405.45,420.95,10340201.0,Laurus Labs hits record high; jumps over 12% in six sessions,"Shares of Laurus Labs jumped 4.74% to Rs 391.40, extending its winning run to sixth consecutive trading session.",positive,positive,3.784516765285988,positive,-1.0352941176470536,negative
2021-04-12 10:50:00.000,417.4,437.9,405.0,418.0,7653617.0,"Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs",Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade,positive,positive,0.1437470052707289,neutral,4.678571428571423,positive
2021-04-12 21:02:32.000,420.0,448.0,417.2,439.65,7116060.0,Laurus Labs Q4 PAT Seen Up 366.3% YoY To Rs. 232.2 Cr: Sharekhan,"Net Sales are expected to increase by 56.6 percent Y-o-Y (up 2 percent Q-o-Q) to Rs. 1,314.3 crore, according to Sharekhan.",neutral,positive,4.678571428571423,positive,-1.8599932363882312,negative
2021-04-22 10:38:37.000,443.2,465.65,442.0,454.0,6196810.0,"D-Street Buzz: Pharma Stocks Edge Higher As Virus Cases Continue To Surge; Cadila Health, Apollo Hospitals Hit New 52-week High","The share price of JB Chemical and Pharmaceuticals was up over 4 percent, hitting new 52-week high on BSE followed by Morepen Labs, Panacea Biotec, Vivimed Labs, Neuland Labs, Laurus Labs, Cadila Healthcare and Apollo Hospitals.",neutral,positive,2.4368231046931434,positive,2.347520842474767,positive
2021-04-23 13:12:00.000,455.8,468.0,454.55,466.5,4019108.0,"Laurus Labs hits new high in subdued market, surges 30% in a month","The company is scheduled to meet on April 29, 2021, to consider and approve the audited financial results of the company for the financial year ended March 31, 2021",positive,neutral,2.347520842474767,positive,-1.0638297872340423,negative
2021-04-25 05:30:00.000,470.0,477.2,461.25,465.0,3040945.0,Laurus Labs Surges 30% in April,Laurus Labs Surges 30% in April,neutral,neutral,-1.0638297872340423,negative,0.042789901583236,neutral
2021-04-26 16:55:00.000,467.4,471.8,454.0,467.6,5143737.0,"Market Movers: Banks shine, HCL Tech slumps; 115 stocks give buy signals","In a reflection of the breadth of the gains in the market, 216 stocks hit their fresh 52-week high during the session. Names included SAIL, ICICI Prudential Life Insurance, JSW Steel, Laurus Labs and Suven Pharma.",positive,positive,0.042789901583236,neutral,0.8273228680526166,neutral
2021-04-28 09:42:00.000,471.4,477.0,465.4,475.3,3504606.0,"Next pharma runup could be led by Aurobindo Pharma, Laurus Labs, Glenmark: Chakri Lokapriya","“While a big run has been made in some of these pharma stocks, another 25% plus run this year is eminently possible.”",neutral,positive,0.8273228680526166,neutral,-5.396957699520729,negative
2021-04-29 05:30:00.000,479.9,483.0,451.05,454.0,9941602.0,BRIEF-India’s Laurus Labs Reports March-Quarter Consol Net PAT Of 2.97 Bln Rupees,BRIEF-India’s Laurus Labs Reports March-Quarter Consol Net PAT Of 2.97 Bln Rupees,neutral,neutral,-5.396957699520729,negative,-0.3956913607386139,neutral
2021-04-29 07:56:00.000,479.9,483.0,451.05,454.0,9941602.0,"Stocks in news: Reliance Inds, Hindustan Unilever, Titan, Bajaj Auto and Ambuja Cements","Hindustan Unilever, Titan and Bajaj Auto, Ambuja Cements, Motherson Sumi, Bajaj Holdings, Shriram Transport, AU SFB, IndiaMart InterMesh and Laurus Labs are among companies scheduled to announce quarterly results today.",neutral,neutral,-5.396957699520729,negative,-0.3956913607386139,neutral
2021-04-29 10:13:00.000,479.9,483.0,451.05,454.0,9941602.0,Laurus Labs Q4FY21 PAT nearly trebles to Rs297cr,"Consolidated revenue from operations was at Rs1,411.93cr in the quarter under review, higher from Rs839.14cr of Q4FY20 and Rs1,288.42cr of Q3FY21.",neutral,positive,-5.396957699520729,negative,-0.3956913607386139,neutral
2021-04-29 15:40:00.000,454.9,466.4,450.0,453.1,6159895.0,Laurus Labs Q4 PAT gallops 170% to Rs 297 cr,"The drug maker’s consolidated net profit soared 170% to Rs 297 crore on 68% surge in net sales to Rs 1,412 crore in Q4 FY21 over Q4 FY20.",neutral,positive,-0.3956913607386139,neutral,4.390563564875484,positive
2021-04-29 17:11:00.000,454.9,466.4,450.0,453.1,6159895.0,Laurus Labs Q4 results: Net profit zooms nearly 3-fold to Rs 297 cr,"Consolidated revenue from operations of the company stood at Rs 1,411.93 crore for the quarter under consideration. It was Rs 839.14 crore for the same period a year ago, it added.",neutral,neutral,-0.3956913607386139,neutral,4.390563564875484,positive
2021-04-29 17:35:00.000,454.9,466.4,450.0,453.1,6159895.0,Laurus Labs consolidated net profit rises 169.34% in the March 2021 quarter,Sales rise 68.26% to Rs 1411.93 crore,positive,positive,-0.3956913607386139,neutral,4.390563564875484,positive
2021-04-29 19:30:56.000,454.9,466.4,450.0,453.1,6159895.0,"Laurus Labs Consolidated March 2021 Net Sales At Rs 1,411.93 Crore, Up 68.26% Y-o-Y",,neutral,neutral,-0.3956913607386139,neutral,4.390563564875484,positive
2021-04-29 22:46:24.000,454.9,466.4,450.0,453.1,6159895.0,Laurus Labs’ Q4 net at ₹297 crore,"Its total revenue increased 68% at ₹1,412 crore",neutral,positive,-0.3956913607386139,neutral,4.390563564875484,positive
2021-04-29 22:58:25.000,454.9,466.4,450.0,453.1,6159895.0,Laurus Labs net surges on higher sales,Drugmaker Laurus Labs has reported a consolidated net profit of ₹297 crore for the quarter ended March on the back of good show in key business segments. The drugmaker had posted a net profit of ₹110.,positive,positive,-0.3956913607386139,neutral,4.390563564875484,positive
2021-04-30 16:05:43.000,454.9,466.4,450.0,453.1,6159895.0,Laurus Labs Q4 Review - Upbeat Numbers Trend Continues: ICICI Direct,Laurus Labs Q4 Review - Upbeat Numbers Trend Continues: ICICI Direct,neutral,neutral,-0.3956913607386139,neutral,4.390563564875484,positive
2021-05-03 11:06:28.000,457.8,480.0,456.1,477.9,7475503.0,Laurus Labs: Diversification To Speed Up In FY23; Add On Declines,There is a perceptible change in the Laurus Labs’ management commentary in the last 18 months that points to growth sustenance for the medium term,neutral,neutral,4.390563564875484,positive,1.6597510373443984,positive
2021-05-03 11:50:34.000,457.8,480.0,456.1,477.9,7475503.0,Laurus Labs shares advance 5% on strong growth outlook,Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model,positive,positive,4.390563564875484,positive,1.6597510373443984,positive
2021-05-05 08:35:37.000,491.9,498.9,487.1,491.0,3366050.0,Laurus Labs (₹491): Buy,"The uptrend that the stock of Laurus Labs established in July last year at about ₹100 continued till the end of the year. However, the bulls lost momentum and consequently, the stock entered a sideway",neutral,negative,-0.1829640170766369,neutral,-2.8784971215028787,negative
2021-05-12 09:14:50.000,490.0,492.55,482.0,486.25,1996413.0,Laurus Labs Is Ramping Up Capacity For Growth Beyond FY23,Laurus Labs says it has completed capacity addition announced a year ago.,neutral,positive,-0.7653061224489796,neutral,-3.814602132895821,negative
2021-05-25 17:07:10.000,515.7,526.5,510.0,523.6,2787275.0,Buy Laurus Labs; Target Of Rs 550: ICICI Direct,"ICICI Direct is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 550 in its research report dated April 30, 2021.",neutral,positive,1.5318983905371295,positive,0.0763941940412485,neutral
2021-06-01 17:28:00.000,532.0,539.0,528.15,536.7,2081422.0,Deven Choksey on 2 midcaps that will head higher,IT company Happiest Minds and Laurus Labs in the pharma space are heading into a good growth path.,neutral,positive,0.8834586466165498,neutral,0.0372786579683216,neutral
2021-06-08 10:12:00.000,575.0,641.65,574.05,609.0,17100437.0,"Laurus Labs trades higher for 8th straight day, soars 73% in 3 months",Shares of Laurus Labs continued their upward journey to hit a new high of Rs 599 on the BSE in intra-day trade on Tuesday,positive,positive,5.913043478260869,positive,-1.0408196454708043,negative
2021-06-18 12:00:06.000,615.0,618.0,590.0,592.0,3864330.0,"Laurus Labs, Alkyl Amines: More steam left after 1,000% gain from 2020 low?",Laurus Labs is likely to maintain its upward journey as long as it doesn’t break the support level of Rs 600 levels,positive,positive,-3.739837398373984,negative,2.909556313993166,positive
2021-06-22 10:12:00.000,607.85,618.0,607.05,615.0,1493082.0,"Laurus Labs gains 2% on robust growth outlook, zooms 70% so far in FY22",The company is looking to build new capacities and facilities that would propel its growth in the coming years,positive,positive,1.1762770420333926,positive,-0.6792819019893146,neutral
2021-06-25 07:35:00.000,629.0,682.8,628.4,649.0,12796543.0,Laurus Labs hits fresh high after CARE upgrades its long term banking facilities to ‘AA’ with stable outlook,The credit rating agency revises the company’s long-term outlook to Stable from Positive.,positive,neutral,3.1796502384737675,positive,3.3607055961070595,positive
2021-06-25 10:05:00.000,629.0,682.8,628.4,649.0,12796543.0,Laurus Labs receives revision in credit ratings from CARE,Long term bank facilities (Rs 1930.64 crore) - CARE AA; Stable Short term bank facilities (Rs 473.20 crore) - CARE A1+ Commercial paper (Rs 200 crore) - CARE A1+ Commercial paper carved out (Rs 100 crore) - CARE A1+,neutral,neutral,3.1796502384737675,positive,3.3607055961070595,positive
2021-06-25 10:12:00.000,629.0,682.8,628.4,649.0,12796543.0,Laurus Labs rallies 5% on credit rating upgrade; stock hits record high,The company is looking to build new capacities/facilities that would propel its growth in the coming years,positive,positive,3.1796502384737675,positive,3.3607055961070595,positive
2021-06-25 11:51:00.000,629.0,682.8,628.4,649.0,12796543.0,Laurus Labs jumps 14% in five sessions,"Laurus Labs jumped 8.15% to Rs 676.60, extending gains for the fifth day.",positive,positive,3.1796502384737675,positive,3.3607055961070595,positive
2021-06-25 12:16:58.000,629.0,682.8,628.4,649.0,12796543.0,Gati Ltd leads gainers in ‘A’ group,"Allcargo Logistics Ltd, Laurus Labs Ltd, Apollo Hospitals Enterprise Ltd and Ashok Leyland Ltd are among the other gainers in the BSE’s ‘A’ group today, 25 June 2021.",positive,neutral,3.1796502384737675,positive,3.3607055961070595,positive
2021-06-25 19:28:00.000,629.0,682.8,628.4,649.0,12796543.0,Prospects in key segments to keep Laurus Labs’ growth trajectory strong,The stock has seen a six-fold jump in value over the last one year,positive,positive,3.1796502384737675,positive,3.3607055961070595,positive
2021-07-02 13:04:00.000,669.6,689.85,662.25,677.4,4642467.0,Laurus Labs receives DRDO licence to manufacture 2-Deoxy-D-Glucose,Powered by Capital Market - Live News,positive,neutral,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-02 13:29:57.000,669.6,689.85,662.25,677.4,4642467.0,Buy Laurus Labs: Target Of Rs 750: Sharekhan,"Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 750 in its research report dated July 01, 2021.",neutral,positive,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-02 14:23:00.000,669.6,689.85,662.25,677.4,4642467.0,Laurus Lab climbs on bagging licence to make 2DG,Laurus Labs gained 1.27% to Rs 675.50 after the drug maker received the license to manufacture and market 2-Deoxy-D-Glucose (2DG) from Defence Research & Development Organisation (DRDO).,positive,positive,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-02 14:45:06.000,669.6,689.85,662.25,677.4,4642467.0,"Laurus Labs gets licence to manufacture, market 2DG",The company has applied for emergency use authorisation,neutral,neutral,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-02 15:01:00.000,669.6,689.85,662.25,677.4,4642467.0,Laurus Labs receives licence from DRDO to manufacture Covid drug 2DG,"2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus Labs said in a regulatory filing.",positive,positive,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-02 15:23:27.000,669.6,689.85,662.25,677.4,4642467.0,Laurus Labs Receives Licence From DRDO To Manufacture And Market COVID Drug 2DG,"2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus Labs said in a regulatory filing.",neutral,positive,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-02 16:01:21.000,669.6,689.85,662.25,677.4,4642467.0,Laurus Labs gets DRDO licence to make anti-COVID drug 2DG,Drugs Controller General of India (DCGI) had on May 1 accorded emergency approval for use of 2DG on COVID-19 patients.,positive,positive,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-02 16:03:00.000,669.6,689.85,662.25,677.4,4642467.0,Laurus Labs receives licence from DRDO to manufacture and market COVID drug 2DG,"2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus Labs said in a regulatory filing.",positive,positive,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-02 16:17:59.000,669.6,689.85,662.25,677.4,4642467.0,DRDO Gives License to Laurus Labs to Manufacture and Market Covid Drug ‘2DG’,Drug firm Laurus Labs on Friday said it has received the licence from Defence Research and Development Organisation to manufacture and market COVID-19 treatment drug 2-Deoxy-D-Glucose (2DG).,neutral,positive,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-02 17:30:00.000,669.6,689.85,662.25,677.4,4642467.0,Laurus Labs gets licence to manufacture DRDO’s anti-COVID drug 2DG,"2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus Labs said in a regulatory filing",positive,positive,1.1648745519713193,positive,-0.0875912408759157,neutral
2021-07-07 10:28:41.000,673.65,685.5,671.2,683.6,2349602.0,Laurus Labs Annual Report Analysis - Scaling Up New Levers To Accelerate Growth: Motilal Oswal,Laurus Labs Annual Report Analysis - Scaling Up New Levers To Accelerate Growth: Motilal Oswal,neutral,neutral,1.4770281303347503,positive,-0.0291928185666392,neutral
2021-07-07 15:41:47.000,685.1,685.85,674.0,684.9,3851571.0,Buy Laurus Labs; Target Of Rs 800: Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 800 in its research report dated July 06, 2021.",neutral,positive,-0.0291928185666392,neutral,-0.8677264109669017,neutral
2021-07-16 17:30:00.000,677.0,679.95,666.05,669.9,1363689.0,"Taking Stock: Market Fails To Hold Record High With Nifty Below 15,850. PSU Banks Stand Out","More than 400 stocks, including Tata Consumer Products, Nelco, Laurus Labs and Shree Renuka Sugars, hit a fresh 52-week high on the BSE",neutral,positive,-1.0487444608567242,negative,-0.2250562640660164,neutral
2021-07-20 13:00:00.000,664.95,672.9,651.5,665.0,1818883.0,"Top stocks in focus: HCL Tech, ACC, Laurus Labs, Jindal Stainless, Bajaj Finance",Check out the stocks that will be in focus during trade today based on recent and latest news developments.,neutral,neutral,0.0075193623580651,neutral,-2.0089955022488724,negative
2021-07-29 08:00:04.000,624.65,625.9,595.0,597.8,6045114.0,"Stocks to Watch: Adani group, Ashok Leyland, Equitas Holdings, HDFC, Maruti","Ajanta Pharma, Dhanuka Agritec, Future Retail, Hawkins Cooker, Indus Towers, JK Lakshmi Cem, Jyothy Labs, Laurus Labs, LIC Housing Finance, Oberoi Realty, PVR, Shriram City, Tech Mahindra, TVS Motor, Union Bank, Welspun Corp, among other companies will report their earnings today.",neutral,neutral,-4.2984071079804735,negative,7.89166666666667,positive
2021-07-29 08:15:29.000,624.65,625.9,595.0,597.8,6045114.0,"Markets may consolidate post Fed meet; Tech Mahindra, TVS Motors in focus","Tech Mahindra, TVS Motors Company, Colgate-Palmolive (India), Container Corporation of India, Laurus Labs, , Deepak Nitrite, Oberoi Realty, Union Bank of India, LIC Housing Finance and Ajanta Pharma are key companies which will announce June quarter earnings today.",neutral,neutral,-4.2984071079804735,negative,7.89166666666667,positive
2021-07-29 16:16:00.000,600.0,648.0,588.0,647.35,8653560.0,Laurus Labs standalone net profit rises 39.87% in the June 2021 quarter,Sales rise 25.78% to Rs 1220.60 crore,positive,positive,7.89166666666667,positive,0.7704160246533128,neutral
2021-07-29 17:06:11.000,600.0,648.0,588.0,647.35,8653560.0,"Laurus Labs Q1FY22 Net Profit Surges 40% To Rs 241 Crore, Led By Anti-HIV Formulation Sales","The earnings before interest, tax, depreciation and ammortisation (EBITDA) margins expanded 210 basis points YoY to 31.3 percent; however, on sequential basis (QoQ), Laurus’ EBITDA margins were down by 250 basis points.",neutral,positive,7.89166666666667,positive,0.7704160246533128,neutral
2021-07-29 17:34:00.000,600.0,648.0,588.0,647.35,8653560.0,Laurus Labs consolidated net profit rises 40.52% in the June 2021 quarter,Sales rise 31.22% to Rs 1278.50 crore,positive,positive,7.89166666666667,positive,0.7704160246533128,neutral
2021-07-29 22:46:05.000,600.0,648.0,588.0,647.35,8653560.0,Laurus Labs Q1 net rises 41% to ₹242 cr.,"Drugmaker Laurus Labs consolidated net profit rose almost 41% to ₹241.61 crore for the quarter ended June. On a sequential basis, however, the net profit declined by 19%.The year-on-year increase in n",positive,positive,7.89166666666667,positive,0.7704160246533128,neutral
2021-07-30 14:03:00.000,600.0,648.0,588.0,647.35,8653560.0,"Laurus Labs logs double-digit growth in PAT, revenue during Q1 led by sustained strong momentum across biz",The company’s EBITDA stood at Rs400cr in the latest quarter increasing by 41% yoy. EBITDA margins were at 31%.,positive,positive,7.89166666666667,positive,0.7704160246533128,neutral
2021-07-30 14:25:00.000,600.0,648.0,588.0,647.35,8653560.0,Laurus Labs rebounds 9% from day’s low after 3 straight sessions of decline,"The management maintains positive outlook across all four businesses -- FDF, APIs, Synthesis and Bio-- on the back of improving demand, and supported by capacity expansion plans planned",positive,positive,7.89166666666667,positive,0.7704160246533128,neutral
2021-07-30 22:59:25.000,600.0,648.0,588.0,647.35,8653560.0,Laurus Labs Q1 Review - Strong Performance Driven By Formulations: ICICI Direct,Laurus Labs Q1 Review - Strong Performance Driven By Formulations: ICICI Direct,neutral,neutral,7.89166666666667,positive,0.7704160246533128,neutral
2021-08-02 11:00:51.000,649.0,664.0,646.8,654.0,3907945.0,"Laurus Labs Q1 Review - Formulation, Synthesis Outshines; API Underperforms: Motilal Oswal","Laurus Labs Q1 Review - Formulation, Synthesis Outshines; API Underperforms: Motilal Oswal",neutral,neutral,0.7704160246533128,neutral,-1.6879562043795655,negative
2021-08-02 14:10:44.000,657.6,659.25,645.1,646.5,1909310.0,Buy Laurus Labs: Target Of Rs 800: Sharekhan,"Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 800 in its research report dated July 30, 2021.",neutral,positive,-1.6879562043795655,negative,-0.6125574272588056,neutral
2021-08-02 17:22:22.000,657.6,659.25,645.1,646.5,1909310.0,Laurus Labs To Focus On Non-HIV Drugs To Drive Future Growth,"“Over the next 3-4 years, we will diversify our entire business from ARV focussed API and formulations to broadly diversified revenue. No therapy will contribute significantly from 2025,” said Satyanarayana Chava, Founder and CEO of Laurus Labs in an interview to Moneycontrol.",neutral,positive,-1.6879562043795655,negative,-0.6125574272588056,neutral
2021-08-06 08:31:00.000,675.0,686.75,673.1,679.5,4028911.0,"Three stock ideas by Osho Krishan of Anand Rathi: Buy Laurus Labs, Equitas",The stock of Laurus Labs is primarily in an uptrend and maintains the cycle of higher highs higher lows on all time frames,neutral,positive,0.6666666666666667,neutral,2.5293388730956936,positive
2021-08-09 09:58:00.000,685.95,710.0,683.2,703.3,7910163.0,Laurus Labs hits record high; rallies 17% in 7 days post Q1 results,"The management holds a positive outlook across all four businesses -- FDF, APIs, Synthesis and Bio -- and believes the outlook remains robust driven by improving demand and supported by capex",positive,positive,2.5293388730956936,positive,-0.1555759847252541,neutral
2021-08-31 17:45:00.000,669.6,671.0,657.2,660.0,1800477.0,"Nifty Healthcare advances; Apollo Hospitals, Ipca Labs emerge top gainers","Fortis and Laurus Labs were also in the fast lane. On the flip side Biocon, Pfizer, and Alkem Lab were struggling.",positive,negative,-1.4336917562724047,negative,-0.4243710215216663,neutral
2021-09-13 17:42:00.000,648.0,666.0,644.2,649.8,3113658.0,"Adani Transmission, Max Financials, Laurus Labs to gain from FTSE rejig",The three stocks are part of several other domestic companies likely to get added to FTSE indices. Adani Transmission is likely to see the largest inflows at $121 million,positive,neutral,0.2777777777777707,neutral,1.6487730061349692,positive
2021-09-14 08:45:00.000,648.0,666.0,644.2,649.8,3113658.0,"Laurus Labs, Unitaid and CHAI to develop HIV medication for children",The innovative incentive program will enable development of an effective pediatric medication that will save the lives of children living with HIV.,neutral,positive,0.2777777777777707,neutral,1.6487730061349692,positive
2021-09-14 12:18:00.000,652.0,664.8,650.3,662.75,2203513.0,Laurus Labs update on development of pediatric formulation of DRV/r,"Despite being available in high-income countries for over a 15-year period, a generic, fixed-dose combination pediatric version of DRV/r is still not available. Through this agreement, Unitaid and CHAI are working with the Company to finally",neutral,neutral,1.6487730061349692,positive,-2.255639097744361,negative
2021-09-14 12:48:00.000,652.0,664.8,650.3,662.75,2203513.0,"Laurus Labs gains on pact with Unitaid, CHAI for pediatric version of HIV drug","Laurus Labs advanced 1.41% to Rs 655 in trade today after the company, along with Unitaid and the Clinton Health Access Initiative, announce agreement to accelerate development of best-in-class second- and third-line HIV medication for children.",positive,positive,1.6487730061349692,positive,-2.255639097744361,negative
2021-09-14 14:27:40.000,652.0,664.8,650.3,662.75,2203513.0,Laurus Labs developing HIV medication for children,The development is based on an agreement with Unitaid and Clinton Health Access Initiative,neutral,neutral,1.6487730061349692,positive,-2.255639097744361,negative
2021-09-14 15:17:58.000,652.0,664.8,650.3,662.75,2203513.0,"Laurus Labs Joins Hands With Unitaid, CHAI To Develop And Commercialise Pediatric HIV Drug Combo",Laurus will be provided with a financial incentive for a portion of their development and commercialisation costs. CHAI will work closely with Laurus Labs to provide technical and regulatory support to enable accelerated generic development and regulatory submission of the medication.,neutral,positive,1.6487730061349692,positive,-2.255639097744361,negative
2021-09-14 23:07:11.000,652.0,664.8,650.3,662.75,2203513.0,Laurus Labs to make HIV drug for children,"Laurus Labs is developing a generic, fixed-dose combination of paediatric version of darunavir boosted with ritonavir (DRV/r) for use as second- and third-line treatment of HIV.This follows an agreeme",neutral,neutral,1.6487730061349692,positive,-2.255639097744361,negative
2021-09-29 14:22:40.000,604.1,623.0,603.25,618.4,3300715.0,Buy Laurus Labs: Target Of Rs 800: Sharekhan,"Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 800 in its research report dated September 28, 2021.",neutral,positive,2.3671577553385124,positive,-0.24240465416936,neutral
2021-10-07 11:49:00.000,644.0,655.0,639.0,650.0,4752210.0,"SBI Card, Laurus Labs, Chambal Fert rally up to 10% on F&O inclusion boost","Firstsource Solutions, Whirlpool of India, Birla Soft and Gujarat State Petronet will also be included in F&O segment w.e.f. October 29, 2021",positive,neutral,0.9316770186335404,positive,-0.908813196884076,negative
2021-10-18 13:51:20.000,645.7,656.0,608.0,616.7,2202488.0,Laurus Labs Ltd in demand,"Laurus Labs Ltd is quoting at Rs 662.95, up 1.84% on the day as on 12:54 IST on the NSE. The stock is up 99.68% in last one year as compared to a 56.03% jump in NIFTY and a 26.33% jump in the Nifty Pharma index.",positive,positive,-4.491249806411646,negative,-2.113821138211382,negative
2021-10-21 06:35:00.000,603.0,603.8,560.35,575.0,4382402.0,"Nifty Pharma joins bear markets; Index sheds 1%; Strides, Granules soar while Gland Pharma, Laurus Labs emerge laggards","Dr Reddy’s also shed 2.65% while Glenmark and Lupin also were around 1.8% on the downside. IPCA Labs, Pfizer, and Cadila were also under heavy pressure.",neutral,neutral,-4.643449419568822,negative,-6.017543859649114,negative
2021-10-22 13:50:25.000,570.0,574.15,520.0,535.7,8555235.0,Laurus Labs Ltd eases for fifth straight session,"Laurus Labs Ltd is quoting at Rs 531.05, down 7.2% on the day as on 13:24 IST on the NSE. The stock jumped 2.95% in last one year as compared to a 51.73% rally in NIFTY and a 21.14% spurt in the Nifty Pharma index.",positive,positive,-6.017543859649114,negative,3.438956197576896,positive
2021-10-27 13:31:31.000,579.0,579.2,522.0,535.55,3783026.0,"Laurus Labs Ltd soars 1.51%, up for third straight session","Laurus Labs Ltd is quoting at Rs 573.1, up 1.51% on the day as on 12:54 IST on the NSE. The stock is up 77.68% in last one year as compared to a 56.03% gain in NIFTY and a 25.04% gain in the Nifty Pharma index.",positive,positive,-7.504317789291891,negative,2.634718631934778,positive
2021-10-28 16:17:00.000,502.9,523.15,488.1,516.15,7495674.0,Laurus Labs Q2 PAT slides 17% YoY to Rs 202 cr,The pharma company’s consolidated net profit fell 16.66% to Rs 201.90 crore on 5.68% increase in net sales to Rs 1203.48 crore in Q2 September 2021 over Q2 September 2020.,neutral,negative,2.634718631934778,positive,-4.730769230769235,negative
2021-10-28 16:31:00.000,502.9,523.15,488.1,516.15,7495674.0,Laurus Labs consolidated net profit declines 16.66% in the September 2021 quarter,Sales rise 5.68% to Rs 1203.48 crore,negative,positive,2.634718631934778,positive,-4.730769230769235,negative
2021-10-28 18:56:21.000,502.9,523.15,488.1,516.15,7495674.0,Laurus Labs’ net down 17 per cent at ₹202 cr in Q2,"Revenue up 6 per cent at Rs 1,203 crore",negative,neutral,2.634718631934778,positive,-4.730769230769235,negative
2021-10-28 22:33:53.000,502.9,523.15,488.1,516.15,7495674.0,Laurus Labs net falls 16%,"Drug maker Laurus Labs has posted a consolidated net profit of ₹203.95 crore for the quarter ended September, a decline of nearly 16% from the ₹242.27 crore in the year-earlier period. Net profit attr",negative,negative,2.634718631934778,positive,-4.730769230769235,negative
2021-10-28 23:11:46.000,502.9,523.15,488.1,516.15,7495674.0,"Laurus Labs Consolidated September 2021 Net Sales At Rs 1,203.48 Crore, Up 5.68% Y-o-Y",,neutral,neutral,2.634718631934778,positive,-4.730769230769235,negative
2021-11-01 06:35:00.000,520.0,521.3,486.0,495.4,7281171.0,"Nifty Pharma gains 1% amid bullish markets; Dr Reddy’s, Lupin and Alkem Lab in the fast lane","Glenmark, Sun Pharma, and Divis Lab gained over 1%. Laurus Labs dragged over 4.5%.",positive,positive,-4.730769230769235,negative,0.0609756097560998,neutral
2021-11-02 02:15:41.000,492.0,503.4,489.6,492.3,3395950.0,Laurus Labs Q2 Review - Subdued Quarter Amid Drag In ARV APIs: ICICI Direct,Laurus Labs Q2 Review - Subdued Quarter Amid Drag In ARV APIs: ICICI Direct,neutral,neutral,0.0609756097560998,neutral,0.9323064450749944,positive
2021-11-02 10:02:31.000,492.0,503.4,489.6,492.3,3395950.0,Laurus Labs: New Growth Levers Taking Shape,"The businesses to track for Laurus Labs, as far as future growth trajectory is concerned, are that of synthesis and biotech",neutral,neutral,0.0609756097560998,neutral,0.9323064450749944,positive
2021-11-11 08:20:00.000,489.55,491.25,455.25,462.6,5024688.0,"Nifty Pharma sheds 1.5% with majority stocks in free fall; Natco dives 6% ahead of Q2; Laurus Labs, Strides, Aurobindo, Sun Pharma drag too","Except for Torrent Pharma and IPCA Lab, all other stocks listed on the Nifty Pharma are trading in the red.",neutral,neutral,-5.505055663364312,negative,-2.0644185041072225,negative
2021-11-12 14:50:05.000,462.6,472.0,451.0,453.05,4237584.0,Laurus Labs Ltd drops for fifth straight session,"Laurus Labs Ltd is quoting at Rs 456.5, down 1.23% on the day as on 13:24 IST on the NSE. The stock jumped 60.74% in last one year as compared to a 41.75% rally in NIFTY and a 17.01% spurt in the Nifty Pharma index.",neutral,positive,-2.0644185041072225,negative,8.267108167770417,positive
2021-11-15 08:05:00.000,453.0,494.45,452.3,490.45,7414352.0,"Nifty Pharma emerges top gainer, index soars 1.5% on broad-based buying; Laurus Labs jumps 9%; Biocon, Gland, NATCO, Glenmark lift too","The index has hovered between an intraday high and low of 13,994.10 and 13,770.90 respectively.",positive,neutral,8.267108167770417,positive,-0.1522224477369596,neutral
2021-11-22 07:38:00.000,485.0,495.95,467.35,474.45,3672754.0,"Stocks in the news: Paytm, Latent View, Reliance Ind, Sun Pharma, IRB Infra and Laurus Labs","Zydus Cadila said it has received approval from the US health regulator to market Decitabine injection, used to treat certain types of cancers, in the American market.",neutral,positive,-2.1752577319587654,negative,3.4851694915254217,positive
2021-11-22 15:04:21.000,472.0,494.4,465.7,488.45,2250858.0,Buy Laurus Labs; Target Of Rs 690: Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 690 in its research report dated November 21, 2021.",neutral,positive,3.4851694915254217,positive,2.479591836734689,positive
2021-11-25 07:07:16.000,505.5,538.75,502.7,536.25,7249609.0,"Trade Spotlight | What Should You Do With ONGC, Laurus Labs, Adani Ports, Zee Stocks?","Here’s what Gaurav Sharma of Globe Capital Markets, recommends investors should do with these stocks when the market resumes trading today.",neutral,neutral,6.083086053412463,positive,-1.8429713211095355,negative
2021-11-25 13:16:18.000,531.75,555.2,520.0,521.95,7908628.0,Laurus Labs Ltd up for third consecutive session,"Laurus Labs Ltd is quoting at Rs 523.45, up 4.25% on the day as on 12:54 IST on the NSE. The stock is up 79.05% in last one year as compared to a 34.53% jump in NIFTY and a 14.62% jump in the Nifty Pharma index.",positive,positive,-1.8429713211095355,negative,-4.481311975591152,negative
2021-12-10 09:16:00.000,520.0,534.8,510.65,525.4,2955256.0,Laurus Labs pays subscription amount of Rs27.60cr as,"Along with the Company, the senior management of the Company also paid the",neutral,neutral,1.038461538461534,positive,-3.0062393647192245,negative
2021-12-15 11:14:00.000,513.0,521.4,508.0,511.6,1134050.0,"Buy Laurus Labs, target price Rs 670: ICICI Direct","Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 27635.02 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.2729044834307947,neutral,-1.968389411422472,negative
2021-12-21 15:27:00.000,489.0,499.6,486.15,498.9,1261411.0,Laurus Labs allots over 7.56 lakh equity shares on exercise of ESOPs,"The total paid up capital of the Company after the allotments stands at Rs.107,47, 18,670/-.",neutral,neutral,2.024539877300609,positive,0.8682634730538967,neutral
2021-12-23 09:51:00.000,501.0,508.5,495.25,505.35,1262459.0,"Buy Laurus Labs, target price Rs 580: Anand Rathi","Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 27017.93 Crore) operating in Pharmaceuticals sector.",neutral,neutral,0.8682634730538967,neutral,-0.9356840342755836,negative
2021-12-24 10:52:54.000,507.65,509.2,498.45,502.9,1145283.0,Why Laurus Labs is Anand Rathi’s top stock pick for the month,"Laurus Labs shares have been under pressure since quiet some time but at this juncture its trading near its crucial support, highlighted Anand Rathi",positive,negative,-0.9356840342755836,negative,4.010401040104012,positive
2021-12-27 17:42:00.000,524.7,532.0,520.2,529.2,2552472.0,"Nifty Pharma leads market revival; Index surges over 1%; Lupin, Cipla among top gainers","Laurus Labs, Torrent Pharma, Natco Pharma, and Glenmark Pharma outperformed. Pfizer was under pressure.",positive,positive,0.8576329331046311,neutral,3.39622641509434,positive
2021-12-28 07:22:18.000,524.7,532.0,520.2,529.2,2552472.0,"Trade Spotlight | What Should You Do With Laurus Labs, Glenmark Pharma, Ashoka Buildcon, And Vakrangee?","Here’s what Karan Pai of GEPL Capital, recommends investors should do with these stocks when the market resumes trading today",neutral,neutral,0.8576329331046311,neutral,3.39622641509434,positive
2021-12-29 05:30:00.000,530.0,555.0,528.35,548.0,4912651.0,"Nifty Pharma Outperforms All Sectoral Indices, Up 1.7%; Laurus Labs Leads","Nifty Pharma Outperforms All Sectoral Indices, Up 1.7%; Laurus Labs Leads",neutral,neutral,3.39622641509434,positive,-1.8272727272727192,negative
2021-12-29 07:10:00.000,530.0,555.0,528.35,548.0,4912651.0,"Nifty Pharma rallies 1.5% as firms gear up for Molnupiravir capsules to treat Covid; Laurus Labs, Sun Pharma, Dr Reddy’s top gainers","Except for the marginal downside in Pfizer and Strides Pharma, all other stocks listed on Nifty Pharma were trading in the fast lane.",positive,neutral,3.39622641509434,positive,-1.8272727272727192,negative
2021-12-29 13:31:16.000,550.0,554.4,536.4,539.95,2773853.0,Laurus Labs Ltd spurts 3.57%,"Laurus Labs Ltd is quoting at Rs 547.9, up 3.57% on the day as on 12:54 IST on the NSE. The stock is up 56.52% in last one year as compared to a 23.22% spurt in NIFTY and a 9.34% spurt in the Nifty Pharma index.",neutral,positive,-1.8272727272727192,negative,-0.0925754489909276,neutral
2021-12-31 13:41:00.000,540.1,544.85,536.65,539.6,1025230.0,"Buy these mid, smallcap stocks for at least 20% returns in 2022","Laurus Labs Ltd, Endurance Technologies Ltd may surge over 30 per cent whereas small cap stocks like Avanti Feeds Ltd, BASF India and Rain Industries could jump up to 40 per cent from current levels",neutral,positive,-0.0925754489909276,neutral,-2.5298988040478383,negative
2022-01-05 06:35:00.000,524.05,545.0,523.15,526.0,5599042.0,"Nifty Pharma stocks trim early gains to trade flat; Alembic Pharma drags while Laurus Labs, Gland Pharma outperform","Cadila and Divis Lab were also under selling pressure. Granules India, Strides Pharma, and IPCA Labs were bullish.",negative,positive,0.3721018986737994,neutral,-0.5859005859005901,neutral
2022-01-05 13:14:50.000,529.1,536.0,522.65,526.0,2910297.0,"Gland Pharma, Laurus Labs Shares Gain On Jefferies’ ‘Buy’ Rating",Here’s what Jefferies has to say about Gland Pharma and Laurus Labs...,neutral,neutral,-0.5859005859005901,neutral,-0.6710140818448076,neutral
2022-01-06 06:17:00.000,529.1,536.0,522.65,526.0,2910297.0,"First up: Jefferies puts buy rating on Gland, Laurus Labs",Jefferies has initiated coverage on Gland Pharma and Laurus Labs with buy ratings as it believes that Indian contract development and manufacturing companies (CDMO) are seeing a significant order flow improvement along with strong growth visibility.,positive,positive,-0.5859005859005901,neutral,-0.6710140818448076,neutral
2022-01-13 10:14:00.000,522.5,528.8,518.3,522.15,1302173.0,"Buy Laurus Labs, target price Rs 670: ICICI Direct","Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 28077.03 Crore) operating in Pharmaceuticals sector.",neutral,neutral,-0.0669856459330187,neutral,0.0864719446579641,neutral
2022-01-17 07:45:00.000,520.85,521.6,504.0,508.95,3029522.0,"Nifty Pharma under pressure on broad-based selloff; Granules shed over 7%; Laurus Labs, Strides among top bears",Nifty Pharma index witnessed a broad-based selloff and has tumbled by nearly 1% since the beginning of trade.,negative,negative,-2.284726888739567,negative,-1.811062163485071,negative
2022-01-21 09:35:00.000,482.0,494.0,475.05,482.85,2246487.0,Laurus Labs signs agreement with MPP to manufacture Molnupiravir,The biotech company signed an agreement with MPP (Medicine Patient Pool) for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.,positive,positive,0.176348547717847,neutral,-2.988792029887928,negative
2022-01-21 11:52:00.000,482.0,494.0,475.05,482.85,2246487.0,Laurus Labs inks pact with MPP to produce molnupiravir,"​​ “We are happy to sign an agreement to manufacture the oral COVID-19 antirviral medication, which is an urgent need of the hour, this is one of the most critical step towards fighting the pandemic and we are happy to contribute to the mission,” Laurus Labs Founder and CEO Satyanarayana Chava said …",neutral,positive,0.176348547717847,neutral,-2.988792029887928,negative
2022-01-21 12:57:31.000,482.0,494.0,475.05,482.85,2246487.0,Laurus Labs inks pact with Medicine Patient Pool for manufacturing molnupiravir,Laurus Labs inks pact with Medicine Patient Pool for manufacturing molnupiravir,positive,positive,0.176348547717847,neutral,-2.988792029887928,negative
2022-01-27 15:40:00.000,440.0,505.8,440.0,497.8,11357355.0,Laurus Labs declines after recording 44% YoY fall in Q3 PAT,Laurus Labs fell 2.36% to Rs 463.45 after the company’s consolidated net profit declined 44% to Rs 154 crore in Q3 FY22 from Rs 273 crore in Q3 FY21.,negative,negative,13.136363636363638,positive,-0.2676977989292133,neutral
2022-01-27 16:40:00.000,440.0,505.8,440.0,497.8,11357355.0,Laurus Labs Q3 results: Net profit drops 44% YoY to Rs 154 crore,"The earnings before interest, tax, depreciation and amortization (EBITDA) decreased 17% YoY to Rs 290 crore. The EBITDA margins dropped by 540 basis points to 28.2%.",negative,negative,13.136363636363638,positive,-0.2676977989292133,neutral
2022-01-27 21:48:00.000,440.0,505.8,440.0,497.8,11357355.0,Pharmaceuticals firm Laurus Labs Q3 net drops 43% to Rs 155 crore,"Pharmaceuticals firm Laurus Labs said its consolidated net profit declined by 43 per cent to Rs 154.97 crore for the third quarter ended December 31, 2021.",negative,negative,13.136363636363638,positive,-0.2676977989292133,neutral
2022-01-27 22:42:09.000,440.0,505.8,440.0,497.8,11357355.0,Laurus Labs Q3 net slides 43% as ARV sales drag,Drugmaker post ₹154.97 cr consolidated net profit,neutral,neutral,13.136363636363638,positive,-0.2676977989292133,neutral
2022-01-28 10:55:27.000,440.0,505.8,440.0,497.8,11357355.0,"Laurus Labs Consolidated December 2021 Net Sales At Rs 1,028.76 Crore, Down 20.15% Y-o-Y",,neutral,neutral,13.136363636363638,positive,-0.2676977989292133,neutral
2022-01-28 14:59:00.000,440.0,505.8,440.0,497.8,11357355.0,Laurus Labs bounces 16% from day’s low on heavy volumes,"The company said its Q3FY22 results were impacted by lower sales of ARV, APIs and formulations due to stocking at channel partners and it expects improvement from January-March quarter (Q4).",neutral,positive,13.136363636363638,positive,-0.2676977989292133,neutral
2022-01-28 17:30:00.000,440.0,505.8,440.0,497.8,11357355.0,"Stocks in news: Route Mobile, BHEL, Canara Bank, PNB and more","Stocks in news: Laurus Labs, Route Mobile, Coforge, Dalmia Bharat, Birlasoft, Indus Towers, RBL Bank, BHEL, Canara Bank, PNB and more",neutral,neutral,13.136363636363638,positive,-0.2676977989292133,neutral
2022-01-31 07:15:17.000,504.3,516.8,500.45,502.95,4283731.0,"Trade Spotlight | What You Should Do With LIC Housing Finance, Laurus Labs, Coforge, Can Fin Homes, Bata India",Here’s what Jayesh Bhanushali of IIFL Securities recommends investors should do with these stocks when the market resumes trading today,neutral,neutral,-0.2676977989292133,neutral,3.9525691699604746,positive
2022-02-01 21:52:19.000,524.45,533.0,523.3,525.0,2381463.0,Buy Laurus Labs; Target Of Rs 580: Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 580 in its research report dated January 28, 2022.",neutral,positive,0.104871770426152,neutral,1.4655500570993616,positive
2022-02-03 13:05:48.000,535.7,536.6,525.5,528.2,1171549.0,"Laurus Labs Ltd soars 0.45%, gains for fifth straight session","Laurus Labs Ltd is quoting at Rs 527.75, up 0.45% on the day as on 12:49 IST on the NSE. The stock is up 52.26% in last one year as compared to a 18.7% jump in NIFTY and a 6.78% jump in the Nifty Pharma.",positive,positive,-1.4000373343289154,negative,-0.0852676456655699,neutral
2022-02-10 09:55:00.000,523.1,545.9,523.1,540.65,3862109.0,Laurus Labs stock ends 2.5% higher after receiving purchase orders from leading Global Life Sciences Company,"The execution of these orders are subject to fulfilment of certain performance obligations, said company.",positive,neutral,3.354999044159808,positive,1.6760811186220863,positive
2022-02-11 12:42:00.000,539.95,568.0,536.6,549.0,7754855.0,Laurus Labs up 8% in two days on purchase orders from global pharma company,The company on Thursday said it has received purchase orders from a leading global life sciences company and the supplies will commence from March 2022.,positive,positive,1.6760811186220863,positive,-2.7398523985239893,negative
2022-03-11 12:26:00.000,553.0,587.15,550.3,580.0,4812613.0,Laurus Labs surges 6% to hit over 4-month high,"Analysts remain optimistic on the company’s outlook for FY23 & FY24 with new capacity addition for commercial usage for FDF and API segments, ARV business and robust growth expected in CS business.",positive,positive,4.882459312839059,positive,-0.9680459179302624,negative
2022-03-11 15:04:34.000,553.0,587.15,550.3,580.0,4812613.0,"D-Street Buzz: Pharma stocks outperform; Sun Pharma, Cipla hit fresh highs","Cipla, Laurus Labs and Sun Pharma which gained over 3 percent each followed by Torrent Pharma, Dr Reddy’s Labs and Aurobindo Pharma.",positive,positive,4.882459312839059,positive,-0.9680459179302624,negative
2022-03-11 17:30:00.000,553.0,587.15,550.3,580.0,4812613.0,"Nifty Pharma surges over 1.5% amid volatile trade; Sun Pharma, Dr Reddy’s, Cipla lead gains","Laurus Labs and Granules India rose 4.27% each to lif the performance of the Index. Cipla rose 3.33% at Rs1,019.90 per piece. Abbot India and Strides Pharma were the top losers in the sector.",positive,positive,4.882459312839059,positive,-0.9680459179302624,negative
2022-03-21 13:31:48.000,593.0,599.0,586.65,593.55,1488850.0,Laurus Labs Ltd sees sustained buying,"Laurus Labs Ltd is quoting at Rs 592, up 1.88% on the day as on 12:54 IST on the NSE. The stock is up 63.81% in last one year as compared to a 16.42% spurt in NIFTY and a 15.02% spurt in the Nifty Pharma index.",positive,positive,0.0927487352445117,neutral,1.4544846610382087,positive
2022-03-23 13:05:15.000,608.0,610.8,600.1,602.95,1724590.0,Laurus Labs Ltd gains for fifth session,"Laurus Labs Ltd is quoting at Rs 600.25, up 1.04% on the day as on 12:49 IST on the NSE. The stock is up 68.54% in last one year as compared to a 18.51% gain in NIFTY and a 14.66% gain in the Nifty Pharma.",positive,positive,-0.8305921052631504,neutral,-3.0491803278688563,negative
2022-03-25 07:50:00.000,610.0,613.9,588.1,591.4,1909069.0,"Stocks to Watch: Axis Bank, M&M, Laurus Labs, Tata Consumer, Auto, OMCs","As per Moody’s, fuel retailers IOC, BPCL and HPCL have together lost around USD 2.25 billion (Rs 19,000 crore) in revenue between Nov-March by keeping petrol and diesel prices unchanged.",neutral,negative,-3.0491803278688563,negative,-0.6060606060606099,neutral
2022-03-28 14:14:13.000,593.75,598.75,590.4,593.2,1428260.0,Buy Laurus Labs: target of Rs 735: Sharekhan,"Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 735 in its research report dated March 25, 2022.",neutral,positive,-0.0926315789473607,neutral,0.3024193548387019,neutral
2022-03-29 10:29:00.000,593.75,598.75,590.4,593.2,1428260.0,ET Emerging Company of the Year 2021: Laurus Labs-A pharma company beats the virus trap to make it big,"It supplies active pharmaceutical ingredients (APIs) to nine out of the 10 largest generic pharma companies and has leadership positions in APIs of antiretrovirals as well as cardiovascular and oncology drugs, persuading the ET Awards jury to pick it as Emerging Company of the Year 2021.",neutral,positive,-0.0926315789473607,neutral,0.3024193548387019,neutral
2022-04-20 13:16:29.000,610.2,614.75,608.0,611.9,867633.0,Pharma and healthcare stocks that top mutual fund houses bet on in March,"Biocon, Laurus Labs, Max Healthcare were among the top healthcare and pharma stocks that mutual funds bought in March",neutral,neutral,0.2785971812520373,neutral,-0.45834015387133,neutral
2022-04-28 16:59:00.000,571.9,590.2,555.3,583.6,4156425.0,Laurus Labs Q4 PAT declines 23% YoY to Rs 230 Cr,The pharmaceutical company posted a 23% fall in consolidated net profit to Rs 230 crore in Q4 FY22 from Rs 297 crore recorded in Q4 FY21.,negative,negative,2.04581220493094,positive,2.061855670103093,positive
2022-04-28 17:44:42.000,571.9,590.2,555.3,583.6,4156425.0,"Laurus Labs Consolidated March 2022 Net Sales at Rs 1,424.83 crore, up 0.91% Y-o-Y",,positive,neutral,2.04581220493094,positive,2.061855670103093,positive
2022-05-03 01:03:00.000,596.0,597.95,573.05,581.5,1335389.0,Laurus Labs will try to make ‘rare’ drugs affordable in India: CEO,"“We want to bring the drugs which are not available in India. The biggest factor is affordability. If you bring a medicine which is not affordable, there is no treatment,” said Chava, who is also the chief executive officer.",neutral,neutral,-2.4328859060402683,negative,-1.1338258031266144,negative
2022-05-03 12:05:18.000,596.0,597.95,573.05,581.5,1335389.0,Buy Laurus Labs; target of Rs 700: Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 700 in its research report dated April 29, 2022.",neutral,positive,-2.4328859060402683,negative,-1.1338258031266144,negative
2022-05-03 21:12:46.000,596.0,597.95,573.05,581.5,1335389.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, short-covering was seen in 30 stocks including HPCL, Petronet LNG, Laurus Labs, Tata Power Company, and Whirlpool of India.",neutral,neutral,-2.4328859060402683,negative,-1.1338258031266144,negative
2022-05-10 14:16:53.000,525.0,543.8,513.25,540.9,2673232.0,Laurus Labs Ltd eases for fifth straight session,"Laurus Labs Ltd is quoting at Rs 539.15, down 0.64% on the day as on 13:19 IST on the NSE. The stock jumped 9.64% in last one year as compared to a 9.98% rally in NIFTY and a 10.19% fall in the Nifty Pharma index.",positive,positive,3.028571428571424,positive,-0.0093283582089467,neutral
2022-06-12 09:38:12.000,540.0,542.8,525.05,526.8,922792.0,Gene therapy to cure leukemia at one-tenth global costs in the works,"ImmunoACT, backed by Laurus Labs is testing their cancer product",neutral,neutral,-2.444444444444453,negative,-0.5573707476455848,neutral
2022-06-16 15:05:47.000,486.1,491.0,461.0,467.0,4574606.0,Laurus Labs: This pharma stock gets a shot in the arm,Relatively better growth visibility and the recent steps towards diversification support our long-term conviction on this scrip.,neutral,positive,-3.9292326681752767,negative,-4.497016197783454,negative
2022-06-16 15:31:42.000,486.1,491.0,461.0,467.0,4574606.0,Laurus Labs Ltd drops for fifth straight session,"Laurus Labs Ltd is quoting at Rs 497.4, down 3.12% on the day as on 13:19 IST on the NSE. The stock tumbled 18.59% in last one year as compared to a 1.45% slide in NIFTY and a 14.29% fall in the Nifty Metal index.",neutral,negative,-3.9292326681752767,negative,-4.497016197783454,negative
2022-07-13 14:16:04.000,516.7,531.7,513.5,521.5,2965795.0,"Laurus Labs Ltd soars 2.96%, up for third straight session","Laurus Labs Ltd is quoting at Rs 507.15, up 2.96% on the day as on 12:49 IST on the NSE. The stock is down 22.94% in last one year as compared to a 1.15% jump in NIFTY and a 13.18% jump in the Nifty Metal index.",positive,positive,0.928972324366161,positive,0.0573942988329738,neutral
2022-07-15 13:04:19.000,522.7,528.5,518.55,523.0,905945.0,"Laurus Labs Ltd spurts 0.51%, rises for fifth straight session","Laurus Labs Ltd is quoting at Rs 524.3, up 0.51% on the day as on 12:44 IST on the NSE. The stock is down 21.61% in last one year as compared to a 0.14% jump in NIFTY and a 13.08% jump in the Nifty Metal.",positive,positive,0.0573942988329738,neutral,-4.110889585113449,negative
2022-07-18 15:04:05.000,505.35,515.0,505.35,508.65,1086454.0,NIIT Ltd leads losers in ‘A’ group,"Bhansali Engineering Polymers Ltd, Zydus Lifesciences Ltd, EPL Ltd and Laurus Labs Ltd are among the other losers in the BSE’s ‘A’ group today, 18 July 2022.",negative,negative,0.6530127634312762,neutral,0.1856556576118797,neutral
2022-07-27 15:32:19.000,520.0,539.0,498.75,525.05,7401985.0,"Laurus Labs Q1 Results: Profit Rises, But Margin Contracts",Net profit of the pharma and biotech company rose 4% year-on-year to Rs 251 crore in the three months through June.,neutral,positive,0.9711538461538374,positive,-0.5714285714285714,neutral
2022-07-27 19:33:11.000,520.0,539.0,498.75,525.05,7401985.0,Laurus Labs Q1 net up 4 per cent at ₹251 crore,"Revenue increases 20 per cent to ₹1,539 crore",neutral,positive,0.9711538461538374,positive,-0.5714285714285714,neutral
2022-07-28 09:38:31.000,520.0,539.0,498.75,525.05,7401985.0,Laurus Labs Q1 net improves marginally,"Key antiretroviral APIs, formulation business witness pricing pressure",positive,negative,0.9711538461538374,positive,-0.5714285714285714,neutral
2022-07-28 11:23:54.000,520.0,539.0,498.75,525.05,7401985.0,Q1 Review | Laurus Labs’ Founder Shares Earnings Insights,Q1 Review | Laurus Labs’ Founder Shares Earnings Insights #Q1WithBQ | Laurus Labs’ net profit rises 15% but margins contact sequentially. Founder & CEO Satyanarayana Chava shares key insights from Q1 report card.,neutral,positive,0.9711538461538374,positive,-0.5714285714285714,neutral
2022-07-29 06:16:58.000,525.0,531.9,515.6,522.0,1900132.0,Laurus Labs Guides For Stable Margin In Rest Of Fiscal,"Margins are expected to remain stable at 29-30%, given the rise in solvent prices, Laurus Labs CEO Satyanarayana Chava says.",neutral,positive,-0.5714285714285714,neutral,-0.019043991620648,neutral
2022-07-29 10:20:38.000,525.0,531.9,515.6,522.0,1900132.0,Laurus Labs Q1 Review - Beats Estimates; Progressing Well On Diversification: Motilal Oswal,Laurus Labs Q1 Review - Beats Estimates; Progressing Well On Diversification: Motilal Oswal,neutral,neutral,-0.5714285714285714,neutral,-0.019043991620648,neutral
2022-10-18 15:46:12.000,513.3,530.5,511.25,527.4,2473143.0,Leading brokerages line up top muhurat picks this Diwali,"Analysts believe stocks like Axis Bank, City Union Bank, CAMS, ITC Ltd, M&M, Titan, Jubilant Foodworks and Laurus Labs can generate mid double digit returns in the medium term",neutral,positive,2.746931618936299,positive,-0.963900963900968,negative
2022-10-20 07:51:21.000,529.1,530.5,517.0,524.0,1708556.0,Buy or sell: Vaishali Parekh recommends 2 stocks to buy today — October 20,Intraday stocks for today: Vaishali Parekh of Prabhudas Lilladher has recommended two stock to buy today — ITC and Laurus Labs,positive,positive,-0.963900963900968,negative,-9.76163450624291,negative
2022-10-21 15:50:17.000,528.6,528.85,475.0,477.0,3747831.0,Laurus Labs consolidated net profit rises 15.31% in the September 2022 quarter,Sales rise 30.94% to Rs 1575.89 crore,positive,positive,-9.76163450624291,negative,-0.2385892116182525,neutral
2022-10-21 17:16:08.000,528.6,528.85,475.0,477.0,3747831.0,Laurus Labs Q2 PAT rises 15% YoY to Rs 233 cr,The pharmaceutical company posted a 15% rise in consolidated net profit to Rs 233 crore in Q2 FY23 from Rs 202 crore recorded in Q2 FY22.,positive,positive,-9.76163450624291,negative,-0.2385892116182525,neutral
2022-10-21 17:30:00.000,528.6,528.85,475.0,477.0,3747831.0,Laurus Labs plunges 7% post Q2 results; Here’s why,"The scrip fell 7.34 per cent to close the day at Rs 487.45 on BSE, taking its year-to-date fall to 9.79 per cent.",negative,negative,-9.76163450624291,negative,-0.2385892116182525,neutral
2022-10-21 17:54:33.000,528.6,528.85,475.0,477.0,3747831.0,"Laurus Labs Q2 profit up 14% at Rs 233 cr, revenue jumps to Rs 1,576 cr","Drug firm Laurus Labs on Friday said its consolidated net profit increased 14 per cent to Rs 233 crore in the second quarter ended September 30, 2022.",positive,positive,-9.76163450624291,negative,-0.2385892116182525,neutral
2022-10-21 17:59:16.000,528.6,528.85,475.0,477.0,3747831.0,Laurus Labs Q2 profit up 14% at Rs 233 crore,The company had reported a net profit of Rs 204 crore in July-September period a year ago.,positive,positive,-9.76163450624291,negative,-0.2385892116182525,neutral
2022-10-21 19:44:13.000,528.6,528.85,475.0,477.0,3747831.0,Q2 Review: Laurus Labs Founder & CEO On Earnings & Growth Targets,Q2 Review: Laurus Labs Founder & CEO On Earnings & Growth Targets #Q2WithBQ | #LaurusLabs’ consolidated profit rises by 15% YoY but misses the street’s expectations.In conversation with Founder & CEO Satyanarayana Chava.,neutral,positive,-9.76163450624291,negative,-0.2385892116182525,neutral
2022-10-21 19:55:26.000,528.6,528.85,475.0,477.0,3747831.0,Laurus Labs’ Q2 net up 15% at ₹233 cr,"Will deliver strong revenue growth and stable EBITDA margins of about 30 per cent in FY2023, says its CEO Satyanarayana Chava",positive,positive,-9.76163450624291,negative,-0.2385892116182525,neutral
2022-10-24 09:20:37.000,482.0,482.65,471.5,480.85,1100710.0,Buy Laurus Labs; target of Rs 610: Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 610 in its research report dated October 22, 2022.",neutral,positive,-0.2385892116182525,neutral,-6.076316880962259,negative
2022-10-25 14:48:31.000,482.2,482.2,450.0,452.9,6857839.0,Laurus Labs hits 4-month low; stock slips 14% in 3 days post mixed Q2FY23,"Despite mixed Q2FY23 performance, brokerages retain their ‘buy’ rating on Laurus Labs with a target price in the range of Rs 610 and Rs 630 per share.",negative,positive,-6.076316880962259,negative,0.8791208791208791,neutral
2022-10-25 15:50:13.000,482.2,482.2,450.0,452.9,6857839.0,Laurus Labs Ltd leads losers in ‘A’ group,"Solara Active Pharma Sciences Ltd, Cartrade Tech Ltd, Shoppers Stop Ltd and Home First Finance Company India Ltd are among the other losers in the BSE’s ‘A’ group today, 25 October 2022.",positive,negative,-6.076316880962259,negative,0.8791208791208791,neutral
2022-10-25 17:30:00.000,482.2,482.2,450.0,452.9,6857839.0,Laurus Labs shares plunge 14% in 3 days. Where are they headed?,"The scrip fell 5.69 per cent to a low of Rs 452.45 on BSE. With this, the scrip has fallen 14.39 per cent in three trading sessions.",negative,negative,-6.076316880962259,negative,0.8791208791208791,neutral
2022-10-26 14:49:00.000,455.0,460.0,450.1,459.0,1714621.0,Laurus Labs - What Lies Ahead?,Laurus Labs - What Lies Ahead?,neutral,neutral,0.8791208791208791,neutral,-2.941176470588235,negative
2022-10-27 11:07:05.000,455.0,460.0,450.1,459.0,1714621.0,Buy Laurus Labs; target of Rs 600: Sharekhan,"Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 600 in its research report dated October 25, 2022.",neutral,positive,0.8791208791208791,neutral,-2.941176470588235,negative
2022-10-27 15:07:00.000,459.0,459.85,443.0,445.5,2498469.0,Laurus Labs Q2 Results Review - Custom Synthesis Outweighs Formulations Decline: ICICI Direct,"Custom synthesis business reported strong growth of 365% YoY, 25% QoQ, supported by accelerated demand from new, existing clients.",neutral,positive,-2.941176470588235,negative,1.7783245721955012,positive
2022-10-31 13:16:30.000,457.0,472.0,456.95,470.5,2066702.0,Laurus Labs gets Form 483 with 1 observation from USFDA,Laurus Labs announced that the US FDA has issued Form 483 with one observation after the pre-approval inspection of its Visakhapatnam facility.,neutral,neutral,2.954048140043764,positive,1.2711864406779665,positive
2022-10-31 15:53:00.000,457.0,472.0,456.95,470.5,2066702.0,Laurus Labs gets one observation from USFDA for pre-approval inspection,"The inspection was conducted from October 24, 2022, to October 28, 2022.",neutral,neutral,2.954048140043764,positive,1.2711864406779665,positive
2022-10-31 17:30:00.000,457.0,472.0,456.95,470.5,2066702.0,"Stocks in news: Bharti Airtel, L&T, Tata Steel, Vedanta and more","Stocks to watch out for today: Bharti Airtel, L&T, Tata Steel, Vedanta, Maruti Suzuki, Laurus Labs and more",neutral,neutral,2.954048140043764,positive,1.2711864406779665,positive
2022-11-03 17:30:00.000,478.0,480.0,462.5,465.55,1501356.0,"Laurus Labs, Coforge, Dabur India to go ex-dividend; stock split, buyback & more","Allsec Technologies (Rs 20 per share dividend), Crisil (Rs 10 per share), Navin Fluorine International (Rs 5 per share), Indian Metals & Ferro Alloys (Rs 5 per share), VIP Industries (Rs 2.5 per share), TCI (Rs 2.5 per share) and Vaibhav Global (Rs 1.5 per share) will go ex-dividend today.",neutral,neutral,-2.6046025104602486,negative,-1.0813704496788032,negative
2022-11-14 13:31:04.000,470.9,474.5,464.05,470.15,1110267.0,Laurus Labs Ltd up for third straight session,"Laurus Labs Ltd is quoting at Rs 466.05, up 2.34% on the day as on 12:49 IST on the NSE. The stock is down 5.09% in last one year as compared to a 1.2% jump in NIFTY and a 7.2% jump in the Nifty Metal index.",positive,positive,-0.1592694839668719,neutral,-1.7648309589623667,negative
2022-11-25 07:59:47.000,452.15,459.75,449.45,455.4,2007784.0,"Stocks to Watch: PNB, Tube Investments, Indian Oil, Laurus Labs, SBI, Lupin",Stocks to Watch: Punjab National Bank (PNB) on Thursday said it received the government’s approval to divest its entire stake (15.22 per cent) in UTI Asset Management Company,neutral,neutral,0.7187880128276014,neutral,-0.8901098901098926,neutral
2022-11-25 17:30:00.000,452.15,459.75,449.45,455.4,2007784.0,"Why are shares of PVR, Laurus Labs, Indian Hotels & Man Infraconstruction rising today?",PVR shares jumped as the multiplex owner opened its first 12-screen superplex in Kerala; Laurus Labs was up on entering share subscription agreement with Ethan Energy,neutral,positive,0.7187880128276014,neutral,-0.8901098901098926,neutral
2022-11-29 10:26:02.000,443.9,443.9,407.5,408.5,12632217.0,"Laurus Labs hits 52-week low, tanks 7% on margin concerns","Laurus has witnessed severe pricing pressure and lower volumes in its ARV formulations portfolio for five quarters now, resulting in significant pressure on core margins, say analyst.",negative,negative,-7.974769092137864,negative,2.9433497536945787,positive
2022-11-29 11:39:15.000,443.9,443.9,407.5,408.5,12632217.0,Laurus Labs Shares Fall On Kotak Downgrade To ‘Sell’,Kotak Institutional has downgraded the fair value of Laurus Labs to Rs 350 apiece from Rs 460 earlier.,neutral,negative,-7.974769092137864,negative,2.9433497536945787,positive
2022-11-29 12:14:08.000,406.0,420.5,405.2,417.95,5892618.0,Laurus Labs slumps to 52-week low as Kotak Institutional Equities downgrades stock,"Kotak has downgraded Laurus Labs to “sell” with a fair value of Rs 350/share, dragging the stock to intraday low of Rs 417",negative,negative,2.9433497536945787,positive,-0.4643409929753515,neutral
2022-11-29 12:50:13.000,406.0,420.5,405.2,417.95,5892618.0,Laurus Labs hits 52-week low; slides about 9% in two days,"Laurus Labs dropped 7.52% to Rs 416.60, extending losses for the second consecutive session.",negative,negative,2.9433497536945787,positive,-0.4643409929753515,neutral
2022-11-29 15:16:04.000,406.0,420.5,405.2,417.95,5892618.0,Laurus Labs Ltd leads losers in ‘A’ group,"Allcargo Logistics Ltd, Bajaj Holdings & Investment Ltd, Aegis Logistics Ltd and Hikal Ltd are among the other losers in the BSE’s ‘A’ group today, 29 November 2022.",positive,negative,2.9433497536945787,positive,-0.4643409929753515,neutral
2022-11-29 17:30:00.000,406.0,420.5,405.2,417.95,5892618.0,"Laurus Labs shares hit 52-week low amid market rally, here’s why",Laurus Labs stock slipped 7.04% to Rs 418.80 (fresh 52-week low) against the previous close of Rs 450.50 on BSE. The stock has been falling for two days,negative,negative,2.9433497536945787,positive,-0.4643409929753515,neutral
2022-11-29 22:21:55.000,406.0,420.5,405.2,417.95,5892618.0,Trade setup for Wednesday: Top 15 things to know before the opening bell,"Based on the open interest future percentage, a short build-up was seen in 69 stocks, including Laurus Labs, ABB India, Shriram Transport Finance, Coal India and Dr Lal PathLabs",neutral,positive,2.9433497536945787,positive,-0.4643409929753515,neutral
2022-11-30 15:31:27.000,419.95,422.0,413.0,418.0,2471897.0,Laurus Labs bounces off 52-week low,"Laurus Labs rose 1.92% to Rs 416.30, reversing recent steep losses on bargain hunting.",neutral,positive,-0.4643409929753515,neutral,2.4213075060532687,positive
2022-12-01 09:42:00.000,419.95,422.0,413.0,418.0,2471897.0,ETMarkets Fund Manager Talk: Why is Sachin Shah of Emkay Investment Managers gung-ho on Zomato?,"“We continue to own large private sector banks like ICICI Bank, HDFC Bank, Axis Bank, and also Federal Bank. We are also optimistic about the CRAMS business for the next few years and have exposure to Divis Laboratories and Laurus Labs. The other pharmaceutical business we like is Sun Pharma for i…",neutral,positive,-0.4643409929753515,neutral,2.4213075060532687,positive
2022-12-09 21:17:41.000,412.75,416.75,411.05,412.45,1412722.0,Laurus Labs Ltd eases for fifth straight session,"Laurus Labs Ltd is quoting at Rs 412.5, down 0.06% on the day as on 13:19 IST on the NSE. The stock tumbled 21.66% in last one year as compared to a 5.59% rally in NIFTY and a 5.09% fall in the Nifty Metal index.",positive,negative,-0.0726832222895242,neutral,-1.9536464021356656,negative
2022-12-13 22:56:08.000,391.15,400.8,390.0,396.75,3030335.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, we saw short build-up in total 58 stocks on Tuesday that included Dr Lal PathLabs, Laurus Labs, Metropolis Healthcare, Can Fin Homes, and BPCL.",neutral,positive,1.4316758276875938,positive,-0.8827238335435058,neutral
2022-12-27 10:22:50.000,377.7,381.2,368.65,375.6,4330700.0,Four employees of Laurus Labs die in fire incident at firm’s Andhra plant,One other employee is undergoing treatment in a hospital after the incident that occurred on Monday evening,negative,neutral,-0.5559968228752888,neutral,-0.2546916890080398,neutral
2022-12-27 11:37:00.000,377.7,381.2,368.65,375.6,4330700.0,3 reasons Laurus Labs is this week’s stock pick,"Laurus Labs will benefit from the growth prospects of the global and domestic pharma indutry as spending on medicines, including Covid-19 vaccines, is likely to increase at 3-6% CAGR by 2026.",neutral,positive,-0.5559968228752888,neutral,-0.2546916890080398,neutral
2022-12-27 17:05:24.000,373.0,379.85,371.35,372.05,1558052.0,"4 dead, 1 injured at Laurus Labs’ Vizag unit fire",The fire occurred in a manufacturing block of API plant,negative,negative,-0.2546916890080398,neutral,-0.1605995717344814,neutral
2022-12-28 13:50:13.000,373.6,375.25,370.75,373.0,1650717.0,Laurus Labs Ltd eases for fifth straight session,"Laurus Labs Ltd is quoting at Rs 374.4, down 0.08% on the day as on 13:19 IST on the NSE. The stock tumbled 31.71% in last one year as compared to a 5.28% rally in NIFTY and a 10.07% fall in the Nifty Metal index.",positive,negative,-0.1605995717344814,neutral,0.0533617929562403,neutral
2023-01-10 07:44:13.000,380.9,382.2,378.0,378.7,607264.0,"Mehul Kothari recommends to buy Laurus Labs, RateGain Travel Technologies","According to the technical analyst from Anand Rathi, Laurus Labs can rally to Rs 400; while RateGain can jump to Rs 330.",positive,positive,-0.5775794171698578,neutral,-3.245382585751982,negative
2023-01-18 17:30:00.000,353.85,355.7,349.15,352.15,1008663.0,"L&T, Apollo Hospitals and Laurus Labs: What should be your trading strategy?",Larsen & Toubro has witnessed a breakout of a symmetrical triangle formation on the daily chart with strong volumes. The momentum indicator RSI is positively poised while the MACD is witnessing a centerline crossover on the upside.,neutral,positive,-0.4804295605482677,neutral,-1.602382302892806,negative
2023-01-20 13:50:09.000,352.6,354.5,346.5,346.95,949770.0,Laurus Labs gets EIR from USFDA for Visakhapatnam-based plant,"The drug maker said that the company has received the establishment inspection report (EIR) from the United States Food & Drug Administration (USFDA) for its manufacturing facility in Visakhapatnam, Andhra Pradesh.",neutral,neutral,-1.602382302892806,negative,-0.0716640389852372,neutral
2023-01-29 11:43:00.000,342.5,360.0,338.0,342.3,3215655.0,"Q3 results this week: L&T, Bajaj Finserv, Sun Pharma, Tech Mahindra, Ashok Leyland and others","Results that will be out on January 30 include Larsen & Toubro, Bajaj Finserv, Tech Mahindra, Bharat Petroleum Corporation, Bajaj Holdings & Investment, GAIL, SRF, Punjab National Bank, REC, Laurus Labs, IIFL Finance, Trident, Exide Industries, Nippon Life India Asset Management, Mazagon Dock Shipbu…",neutral,neutral,-0.0583941605839382,neutral,-2.961876832844581,negative
2023-01-30 08:47:43.000,342.5,360.0,338.0,342.3,3215655.0,"Stocks that will see action on January 30, 2023","Buzzing stocks: L&T, Tech Mahindra, PNB, Nippon India AMC, NMDC Steel, GRSE, HFCL, Laurus Labs, Trident, Tube Investments, Snowman Logistics, BPCL, Bajaj Finserv, GAIL India, Exide, Emkay Financial, SRF, Welspun, REC, INOX Leisure, Mazagon Dock Shipbuilders",neutral,neutral,-0.0583941605839382,neutral,-2.961876832844581,negative
2023-01-30 12:59:46.000,341.0,341.0,324.05,330.9,5409858.0,Laurus Labs Q3 Results: Profit Rises But Misses Estimates,Net profit of the Hyderabad-based pharma and biotech company rose 32% year-on-year to Rs 203 crore in the quarter ended December.,neutral,positive,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-30 13:16:09.000,341.0,341.0,324.05,330.9,5409858.0,Laurus Labs Q3 PAT rises 32% YoY to Rs 203 cr,"The pharmaceutical company’s consolidated net profit jumps 32.08% to Rs 203.04 crore on 50.16% surge in revenue from operations to Rs 1,544.82 in Q3 FY23 over Q3 FY22.",positive,positive,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-30 13:31:23.000,341.0,341.0,324.05,330.9,5409858.0,Laurus Labs posts 32 per cent profit jump on demand for drug ingredients,Laurus Labs shares rose as much as 5.3 per cent to ₹360 on Monday,positive,positive,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-30 13:44:44.000,341.0,341.0,324.05,330.9,5409858.0,India’s Laurus Labs posts 32% profit jump on demand for drug ingredients,"India’s Laurus Labs Ltd reported a 32.1% rise in third-quarter profit on Monday, boosted by strong demand in its businesses that make chemicals and other ingredients used in medicines",positive,positive,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-30 14:44:45.000,341.0,341.0,324.05,330.9,5409858.0,"Laurus Labs Standalone December 2022 Net Sales at Rs 1,500.70 crore, up 60.92% Y-o-Y",,positive,neutral,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-30 14:44:54.000,341.0,341.0,324.05,330.9,5409858.0,"Laurus Labs Consolidated December 2022 Net Sales at Rs 1,544.82 crore, up 50.16% Y-o-Y",,positive,neutral,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-30 17:30:00.000,341.0,341.0,324.05,330.9,5409858.0,"Hindustan Zinc, 2 other stocks to go ex-dividend; TechM, L&T, GAIL, PNB, Mazagon Q3 results today","GAIL, PNB, BPCL, Laurus Labs and Mazagon Dock Shipbuilders are among dozen companies that will disclose their December quarter results today. Others included Exide Industries, Nippon Life India Asset Management, Inox Leisure and CSB Bank.",neutral,neutral,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-30 19:40:09.000,341.0,341.0,324.05,330.9,5409858.0,Laurus Labs’ Q3 net up 32 pc at ₹203 cr,"Total revenue increased 50 per cent to ₹1,545 crore",neutral,positive,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-30 21:36:31.000,341.0,341.0,324.05,330.9,5409858.0,Laurus Labs net surges over 31% in Q3,"The higher net profit came on a nearly 50% increase in the total income to ₹1,546.25 crore",positive,positive,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-31 10:32:28.000,341.0,341.0,324.05,330.9,5409858.0,Laurus Labs Shares Slide After Analysts Raise A Concern,"The management has maintained its guidance of Rs 6,500 crore in revenue and stable Ebitda margins of 28% for FY23.",neutral,positive,-2.961876832844581,negative,1.3771186440678005,positive
2023-01-31 12:54:50.000,330.4,347.8,329.2,334.95,2857033.0,Laurus Labs shares tumble as Jefferies cuts target price,"Choice Equity Broking, too, expects muted growth for the drugmaker because of a decline in margins due to a change in product mix and operating de-leverage",negative,negative,1.3771186440678005,positive,2.195488721804515,positive
2023-01-31 14:06:55.000,330.4,347.8,329.2,334.95,2857033.0,Laurus Labs stock feels the heat as margin woes expected to linger,"Stiff competition in the ARV formulation market and API has created high uncertainty for Laurus Labs regarding the base business, particularly in the past six-eight quarter",negative,negative,1.3771186440678005,positive,2.195488721804515,positive
2023-01-31 14:26:00.000,330.4,347.8,329.2,334.95,2857033.0,Prices can’t go down further in APIs or it will turn unviable for new entrants: Laurus Labs CEO,"“If you look at the current nine months financials, the ARV APIs and formulation put together contributed only 35% of revenue came from ARVs. It used to be 85% during actual times but now it is 35% and we do hope the ARV revenues contribution will be similar to what we have seen in this current fina…",neutral,neutral,1.3771186440678005,positive,2.195488721804515,positive
2023-01-31 15:13:31.000,330.4,347.8,329.2,334.95,2857033.0,"Laurus Labs slips 5%, hits over 2-year low post December quarter results","Laurus Labs delivered operationally in-line performance, led by healthy traction in CDMO-Synthesis/Non-ARV API segment",negative,positive,1.3771186440678005,positive,2.195488721804515,positive
2023-01-31 15:41:19.000,330.4,347.8,329.2,334.95,2857033.0,Q3 Review| Laurus Labs Growth Strategies For Coming Quarters,Q3 Review| Laurus Labs Growth Strategies For Coming Quarters #LaurusLabs’ profit jumps 32% year-on-year on demand for drug ingredients. Revenues too surge 50%.CEO Dr. Satyanarayana Chava talks about the company’s growth plans in the coming quarters.,neutral,positive,1.3771186440678005,positive,2.195488721804515,positive
2023-02-02 15:31:57.000,340.9,340.9,327.55,331.0,1379667.0,Buy Laurus Labs; target of Rs 400: ICICI Direct,"ICICI Direct is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 400 in its research report dated January 31, 2023.",neutral,positive,-2.904077442065115,negative,0.210147102972077,neutral
2023-02-02 16:43:07.000,340.9,340.9,327.55,331.0,1379667.0,Hold Laurus Labs; target of Rs 368: Sharekhan,"Sharekhan recommended Hold rating on Laurus Labs with a target price of Rs 368 in its research report dated January 31, 2023.",neutral,positive,-2.904077442065115,negative,0.210147102972077,neutral
2023-02-03 17:30:00.000,340.9,340.9,327.55,331.0,1379667.0,"For LIC, Adani is not the biggest problem","Apart from Adani Group stocks, LIC’s holdings in companies like Future Lifestyle Fashions, Piramal Enterprises, Omaxe, Indus Towers, Laurus Labs, Jet Airways (India), Sunteck Realty, Bombay Dyeing, GTL Infrastructure, Aurobindo Pharma and Jaypee Infratech among others have also taken a huge beating …",neutral,neutral,-2.904077442065115,negative,0.210147102972077,neutral
2023-02-13 08:53:52.000,340.0,341.8,331.4,333.0,897737.0,"Stocks that will see action on February 13, 2023","Buzzing stocks: Reliance Industries, Chemplast Sanmar, BEML, Sun Pharma, Thermax, Sintex, Laurus Labs, Excel Industries, and more",neutral,neutral,-2.0588235294117645,negative,-1.1940298507462688,negative
2023-03-14 10:54:38.000,305.35,307.75,300.25,305.25,1493771.0,Time for pharma industry to move from Make in India to Invent in India: Laurus Labs CEO,"The government should look into incentivising disruptive research in the healthcare sector, says Satyanarayana Chava, the founder of the Hyderabad-based company that sells active pharmaceutical ingredients in over 55 countries.",neutral,neutral,-0.0327493040772958,neutral,-0.3919007184846468,neutral
2023-03-14 14:27:00.000,306.2,310.75,304.4,305.0,1230559.0,"Nifty Pharma index hits 2-year low; Cipla, Divis, Laurus Labs at 52-wk lows","Analysts said the pace of US FDA inspections has again picked-up in the last few months post Covid, and they have seen increased incidents with 483 observations and adverse outcomes",negative,positive,-0.3919007184846468,neutral,0.3442058678905135,neutral
2023-03-14 17:30:00.000,306.2,310.75,304.4,305.0,1230559.0,"RIL, Tata Consumer, Laurus Labs: These 14 popular shares are trading at 52-week lows; which stock to buy?","Brokerage Sharekhan last month gave a ‘Buy’ rating to Relaxo Footwears with a target price of Rs 930. Likewise, B&K Securities is bullish on Crompton Greaves Consumer Electricals with a target price of Rs 363.",neutral,positive,-0.3919007184846468,neutral,0.3442058678905135,neutral
2023-03-20 12:44:17.000,299.0,306.5,298.85,305.55,1064879.0,"Reliance, Wipro, Jubilant FoodWorks, Crompton Greaves hit 52-week lows","Max Financial, Mphasis, Emami, HDFC AMC, Pfizer, Network18, Godrej Agrovet, Laurus Labs and Motilal Oswal Financial were among 34 stocks from the S&P BSE 500 index hit their respective 52-week lows.",positive,neutral,2.190635451505021,positive,-0.2941176470588161,neutral
2023-04-05 17:57:12.000,306.0,308.6,303.65,304.05,1139340.0,Broker’s call: Laurus Labs (Buy),Broker’s call: Laurus Labs (Buy),neutral,neutral,-0.6372549019607806,neutral,-0.4590163934426154,neutral
2023-04-06 21:48:16.000,306.0,308.6,303.65,304.05,1139340.0,P. B. Siddhartha college inks pact with pharma company to impart industry skills for students,"City-based P. B. Siddhartha College of Arts and Science has inked an MoU with pharma major Laurus Labs Ltd. to offer industry skills, internships and career opportunities to its students",positive,positive,-0.6372549019607806,neutral,-0.4590163934426154,neutral
2023-04-18 22:11:35.000,310.75,316.5,307.25,311.5,3467512.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the OI percentage, 56 stocks, including ICICI Lombard General Insurance Company, Crompton Greaves Consumer Electricals, Laurus Labs, Navin Fluorine International and Coforge, saw long build-ups.",neutral,neutral,0.2413515687851971,neutral,-1.7917133258678684,negative
2023-04-27 08:58:51.000,301.8,304.5,287.3,296.0,7449681.0,Stocks that will see action today - April 27,"Buzzing stocks on April 27: ACC, Axis Bank, Bajaj Finserv, CPCL, Coforge, Embassy REIT, Gateway Distriparks, Hindustan Unilever, Indian Hotels, Laurus Labs, LTIMindtree, Motilal Oswal, Mphasis, Shriram Finance, Surya Roshini, Tech Mahindra, Trent, Videocon Industries, Welspun India, Wipro, Tata Po…",neutral,neutral,-1.921802518223993,negative,9.785714285714278,positive
2023-04-27 09:30:00.000,301.8,304.5,287.3,296.0,7449681.0,"Q4 results today: What’s in store for HUL, Axis Bank, Bajaj Finserv, Wipro, LTIMindtree, Tech Mahindra and Laurus Labs?","Nifty companies, including HUL, Axis Bank, and Wipro, are set to announce their fourth-quarter earnings today. HUL is expected to report double-digit revenue growth led by price hikes, while Axis Bank’s bottom line is likely to be dampened due to one-off costs from integrating Citibank India’s busin…",neutral,positive,-1.921802518223993,negative,9.785714285714278,positive
2023-04-27 16:46:49.000,280.0,311.4,278.85,307.4,15661633.0,"Laurus Labs Q4 Results: Profit Drops 55%, Misses Estimates",Net profit of the pharma and biotech company slumped 55% year-on-year to Rs 103 crore.,neutral,negative,9.785714285714278,positive,1.2987012987012987,positive
2023-04-27 19:47:41.000,280.0,311.4,278.85,307.4,15661633.0,Laurus Labs Q4 net slumps,Interim dividend of ₹1.20 per equity share of ₹2 each,negative,neutral,9.785714285714278,positive,1.2987012987012987,positive
2023-04-28 09:33:17.000,280.0,311.4,278.85,307.4,15661633.0,"Laurus Labs Standalone March 2023 Net Sales at Rs 1,279.34 crore, down 7.14% Y-o-Y",,negative,neutral,9.785714285714278,positive,1.2987012987012987,positive
2023-04-28 09:33:59.000,280.0,311.4,278.85,307.4,15661633.0,"Laurus Labs Consolidated March 2023 Net Sales at Rs 1,380.90 crore, down 3.08% Y-o-Y",,negative,neutral,9.785714285714278,positive,1.2987012987012987,positive
2023-04-28 11:18:18.000,280.0,311.4,278.85,307.4,15661633.0,Laurus Labs Q4 Results Review: Brokerages Cut Estimates On Uncertain FY24 Outlook,"The drugmaker’s net profit was down 55% year-on-year to Rs 103 crore in the quarter ended March, as per an exchange filing.",neutral,negative,9.785714285714278,positive,1.2987012987012987,positive
2023-04-28 22:54:51.000,280.0,311.4,278.85,307.4,15661633.0,Buy Laurus Labs; target of Rs 340 : Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 340 in its research report dated April 27, 2023.",neutral,positive,9.785714285714278,positive,1.2987012987012987,positive
2023-05-01 20:29:56.000,308.0,317.9,307.4,312.0,4542114.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the OI percentage, 83 stocks, including Aarti Industries, Syngene International, IndiaMART InterMESH, Laurus Labs, and IDFC First Bank, saw long build-ups.",neutral,positive,1.2987012987012987,positive,2.9740965781899624,positive
2023-05-02 08:33:40.000,308.0,317.9,307.4,312.0,4542114.0,Hold Laurus Labs; target of Rs 338: Sharekhan,"Sharekhan recommended Hold rating on Laurus Labs with a target price of Rs 338 in its research report dated April 28, 2023.",neutral,positive,1.2987012987012987,positive,2.9740965781899624,positive
2023-05-02 15:45:10.000,312.7,322.95,311.15,322.0,3139184.0,Laurus Labs shares extend gains on USFDA approval for HIV drug,"Laurus Labs closes 1.3 percent higher at Rs 311.60, with volumes of 45.5 lakh shares. The stock has gained 6 percent in two sessions",positive,positive,2.9740965781899624,positive,-1.2230995510140854,negative
2023-05-02 21:31:50.000,312.7,322.95,311.15,322.0,3139184.0,U.S. FDA gives tentative nod for Laurus’ paediatric ARV oral dispersible film drug,Laurus Labs has received U.S. FDA’s tentative approval for paediatric antiretroviral drug Dolutegravir 5mg and 10mg in oral dispersible film (ODF) dosage form.,neutral,positive,2.9740965781899624,positive,-1.2230995510140854,negative
2023-05-03 08:42:56.000,312.7,322.95,311.15,322.0,3139184.0,"Stocks to watch on May 3, 2023","Buzzing stocks: Laurus Labs, Bharti Airtel, Godrej Consumer, Mukund, ABB India, Adani Wilmar, Anupam Rasayan India, Bajaj Consumer Care, Cholamandalam Investment, Godrej Properties, Havells India, Reliance Power, Sula Vineyards, Tata Chemicals, Titan Company, Vimta Labs and Vishnu Chemicals",neutral,neutral,2.9740965781899624,positive,-1.2230995510140854,negative
2023-05-10 17:30:00.000,333.0,334.65,299.3,320.7,8693439.0,"Laurus Labs, Coforge shares to turn ex-dividend; L&T, Gujarat Gas Q4 results today",Shares of Coforge would turn ex-dividend today. Coforge had announced an interim dividend of Rs 19 per share and the record date for the same is today. The dividend will be paid on May 26.,neutral,neutral,-3.693693693693697,negative,-3.8354037267080816,negative
2023-05-11 17:30:00.000,322.0,322.2,308.15,309.65,4328263.0,"Laurus Labs shares plunge 10% in afternoon trade, slip below Rs 300 level","Laurus Labs delivered a miss on Q4 earnings, led by a sharp decline in the Synthesis (CDMO) business. Motilal Oswal Securities expects FY24 to be a year of consolidation for Laurus Labs in terms of sales.",negative,negative,-3.8354037267080816,negative,0.3226326826907565,neutral
2023-05-11 17:32:24.000,322.0,322.2,308.15,309.65,4328263.0,Laurus Labs steps up focus on R&D with a pipeline of 60 products,Laurus is adopting a product-specific approach instead of market-specific strategies.,neutral,neutral,-3.8354037267080816,negative,0.3226326826907565,neutral
2023-05-31 17:30:00.000,334.65,345.0,333.05,340.05,6970373.0,"Laurus Labs further invests in gene therapy tech, increases its stake in lmmunoACT to 33.86%",ImmunoACT has portfolio of Chimeric Antigen Receptor T cells (CAR-T cells) therapy assets under various development stages for the treatment of multiple auto immune diseases and oncology indications.,positive,neutral,1.613626176602431,positive,1.0950503723171263,positive
2023-05-31 20:22:00.000,334.65,345.0,333.05,340.05,6970373.0,Laurus Labs invests Rs 80 crore in cell & gene therapy firm ImmunoACT,"The fresh infusion of capital will enable ImmunoACT to fast-track the scale-up of its lead candidate HCAR-19 by expansion of the multi-location cGMP facilities and R&D of new product pipeline. “This investment will further help ImmunoACT to gear up for the manufacture of more treatments,” said Satya…",neutral,positive,1.613626176602431,positive,1.0950503723171263,positive
2023-06-01 07:42:55.000,334.65,345.0,333.05,340.05,6970373.0,"Buzzing Stocks: Coal India, MOIL, Laurus Labs, Max Healthcare & others in focus today",Stocks to Watch: Check out the companies making headlines before the opening bell today.,neutral,neutral,1.613626176602431,positive,1.0950503723171263,positive
2023-06-01 09:31:18.000,334.65,345.0,333.05,340.05,6970373.0,Laurus Labs shares rise 3% after upping stake in gene therapy company,The company has signed definitive agreements to acquire additional stake of 7.24% in Immunoadoptive Cell Therapy Private Limited (lmmunoACT) for a cash consideration of Rs 80 crore.,positive,positive,1.613626176602431,positive,1.0950503723171263,positive
2023-06-01 17:30:00.000,342.45,347.0,338.5,346.2,2923801.0,"Coal India, SAIL, Vedanta, HDFC Life among stocks to watch out for today","Stocks to watch out for today: Coal India, SAIL, Vedanta, HDFC Life, Laurus Labs and more",neutral,neutral,1.0950503723171263,positive,-2.09770114942529,negative
2023-06-15 21:02:27.000,368.05,374.95,366.75,366.9,2933229.0,"U.S.FDA issues EIRs to Laurus, Natco plants in AP","Drugmakers Laurus Labs and Natco Pharma have received establishment inspection reports (EIR) from the U.S. Food and Drug Administration (U.S. FDA) for formulations manufacturing facilities in Visakhapatnam, Andhra Pradesh.",neutral,neutral,-0.3124575465290135,neutral,-1.084010840108401,negative
2023-06-19 12:21:34.000,366.4,367.55,363.0,365.3,1296808.0,Laurus Labs Partners With IIT Kanpur For Novel Gene Therapy Assets,"As per MOA, Laurus labs will in-license few gene therapy assets and will provide research grant for advancing these products through the pre-clinical development.",neutral,positive,-0.3002183406113444,neutral,-0.3278240677503042,neutral
2023-06-19 21:11:02.000,366.4,367.55,363.0,365.3,1296808.0,Laurus Labs inks pact with IIT Kanpur for gene therapy assets,"As per the pact, Laurus Labs will provide research grants and launch these products in India and emerging markets",positive,neutral,-0.3002183406113444,neutral,-0.3278240677503042,neutral
2023-07-10 22:02:54.000,358.5,361.0,355.55,356.85,1151698.0,Trade setup for Tuesday: Top 15 things to know before the opening bell,"A short build-up was seen in 79 stocks, including Aarti Industries, Dalmia Bharat, Atul, Laurus Labs and Jubilant Foodworks. An increase in OI along with a price fall indicates a build-up of short positions",neutral,positive,-0.4602510460250983,neutral,-1.1623021985716382,negative
2023-07-27 15:49:17.000,338.0,348.8,331.5,336.95,9624618.0,Laurus Labs’ Q1 net down 90 pc at ₹25 cr,"Laurus Lab’s net profit declined 90 per cent to ₹25 crore in the first quarter ended June 30, 2023,",neutral,negative,-0.3106508875739678,neutral,3.687315634218289,positive
2023-07-27 15:54:23.000,338.0,348.8,331.5,336.95,9624618.0,"Laurus Labs Q1 Results: Profit Falls 90%, Misses Estimates",Net profit of the Hyderabad-based company slumped 90% year-on-year to Rs 25 crore in the quarter ended June.,neutral,negative,-0.3106508875739678,neutral,3.687315634218289,positive
2023-07-27 20:06:25.000,338.0,348.8,331.5,336.95,9624618.0,Lower sales drag Laurus Labs’ Q1 net down 90%,Company attributes performance to transient demand weakness in both APIs and finished dose form businesses,negative,negative,-0.3106508875739678,neutral,3.687315634218289,positive
2023-07-28 09:34:10.000,338.0,348.8,331.5,336.95,9624618.0,Laurus Labs slips 2% on dismal earnings; brokerages foresee bleak growth,"Laurus Labs registered an EBITDA margin of 14.1 percent in April-June, the lowest-ever on a quarterly basis.",negative,negative,-0.3106508875739678,neutral,3.687315634218289,positive
2023-07-28 10:05:00.000,338.0,348.8,331.5,336.95,9624618.0,"Hot Stocks: Brokerages on Shriram Finance, ACC, Nestle India, and Laurus Labs",HSBC maintained a buy rating on Shriram Finance with a target price of Rs 228. A 4% profit beat was led by lower provisions despite higher-than-estimated operating costs.,neutral,positive,-0.3106508875739678,neutral,3.687315634218289,positive
2023-07-28 11:27:31.000,338.0,348.8,331.5,336.95,9624618.0,Q1 Review: Muted June Quarter For Laurus Labs,"Q1 Review: Muted June Quarter For Laurus Labs #Q1WithBQ | Laurus Labs’ first-quarter profit misses estimates, declines by 90% year-on-year.Founder and CEO Satyanarayana Chava discusses the company’s earnings and outlook for coming quarters.",neutral,negative,-0.3106508875739678,neutral,3.687315634218289,positive
2023-07-31 21:55:20.000,353.75,359.0,352.0,357.4,2471587.0,Buy Laurus Labs; target of Rs 410: Motilal Oswal,"Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 410 in its research report dated July 27, 2023.",neutral,positive,1.0318021201413363,positive,1.4452473596442437,positive
2023-08-06 19:29:47.000,393.95,403.85,390.25,400.4,5191957.0,Trade setup for Monday: Top 15 things to know before the opening bell,"Based on the OI percentage, 64 stocks were on the short-covering list. These included Bharti Airtel, Axis Bank, Laurus Labs, Torrent Pharmaceuticals, and Jubilant Foodworks. A decrease in OI along with a price increase is an indication of short-covering.",neutral,neutral,1.637263612133517,positive,2.227753578095828,positive
2023-08-13 18:45:08.000,388.2,388.6,380.2,385.0,1479777.0,Trade setup for Monday: Top 15 things to know before the opening bell,"A short build-up was seen in 66 stocks, including Apollo Tyres, Max Financial Services, Britannia Industries, Info Edge India, and Laurus Labs. An increase in OI along with a fall in price points to a build-up of short positions.",neutral,positive,-0.8243173621844381,neutral,1.8853205044857624,positive
2023-08-27 19:09:13.000,388.95,393.2,385.65,389.3,1054248.0,Trade setup for Monday: Top 15 things to know before the opening bell,"Based on the OI percentage, we have seen a long unwinding in 94 stocks, including GMR Airports Infrastructure, Coforge, Laurus Labs, BHEL, and Astral. A decline in OI and price indicates long unwinding.",neutral,positive,0.0899858593649627,neutral,-0.1403061224489825,neutral
